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Knowledge of liver regeneration following reduced liver transplantation is limited. 
In order to fully examine the regenerative process, each component of the 
transplant procedure was examined in isolation. The effects of warm hepatic 
ischaemia, portal venous occlusion, hepatic sympathetic denervation, graft storage 
and flushing of the liver with preservation solutions at different temperatures were 
studied. Finally these factors were combined, and the regenerative capacity of the 
partial orthotopic liver graft in allogeneic combination studied. 
In the first part, partial hepatectomy (ph) was performed on fasted male Long-
Evans rats, with animals then divided into groups: group A had ph only; group B had 
ph + 40 minutes ischaemia; group C had ph + 40 mins ischaemia + temporary 
portocaval shunt; group D had ph + orthotopic autograft; group E had ph plus 
orthotopic allograft after 4 hrs cold storage; Group F were sham-operated. Animals 
were sacrificed after periods of 4, 24, 48, 72 and 96 hrs and the livers weighed, 
examined histologically, and assayed for thymidine kinase (TI<) and ornithine 
decarboxylase (ODC) activity by standard methods. Serum aspartate 
aminotransferase (AST) was recorded. A liver mass index (LMI) was derived for 
each animal as an index of liver to mass ratio. Mitotic figures per 1000 cells were 
counted (mitotic index or MI). In group A (ph), peak levels of TI( activity (dpm per 
mg protein) (36 021 + -8060) and MI (25 + -7) were measured at 24 hrs, with 
ii 
restitution of the liver mass to that of shams (group F) by 96 hrs. In groups B, C, D 
and E maximal Tl( and MI was observed at 48 hrs. The magnitude of the peak 
response in these groups appeared to correlate with the duration of portal venous 
occlusion, with greatest increases occurring in those groups where portal stasis was 
most prolonged. The increase in liver mass for these groups was also delayed with 
respect to controls. The anticipated peak in ODC was seen at 4 hrs in group A. The 
ODC response in the other groups was disorganized. The effect of hepatic 
dearterialization on liver regeneration was examined in group K. In these animals 
Tl( activity (36 308+-6 063) and LMI recorded at 24 hours (0.476+-0.33) was no 
different to that of controls, although the MI (5 +-3) was diminished at this time. 
This suggested a comparable rate of regenerative growth to partially 
hepatectomized controls. The effect of in situ liver flushing on hepatic regeneration 
was studied by dividing animals into 6 groups: group A ph only (controls); group G 
0 0 
ph + Ringers lactate flush at 37 C; group H ph + Ringers lactate flush at 4 C; group 
0 
I ph + University of Wisconsin solution flush at 4 C; group J ph + Euro-Collins 
0 
solution flush at 4 C. In groups G ( 4 789 + -618), H ( 10531 + -3572), I ( 11790 + -
= 5278) and J (7130 + -2060) Tl( activity was diminished at 24 hrs (p < 0.05) with 
respect to controls. The MI was similarly diminished: group G (1 +-0), group H (1 +-
1 ), group I ( 1 + -0) and group J (1 + -O)(p < 0.01 ). Instead, peak Tl( activity was 
recorded at 48 hrs: groups H (24916 +-6434 ), I (33655 + -6697) and J (26676 +-3932). 
The MI demonstrated a similar pattern, and was greater than the MI of group A 
(9 +-3) at this time: groups H (18 +-4)(p < 0.01), I ( 40+-6)(p < 0.01) and J (17 +-
3 )(p < 0.05). The LMI showed restitution to that of shams (group F) by 96 hrs in 
groups H, I and J. ODC activity was disorganised in all but group A. 
The results of these studies suggest that hepatic ischaemia of 40 minutes duration 
delays the onset of liver regeneration following partial hepatectomy. This delayed 
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response may reflect the effects stimulation of cytokine release or diversion of 
hepatocyte synthetic function towards essential protein synthesis. Portal venous 
stasis appears to enhance the proliferative response. Hepatic denervation by surgical 
means has no apparent effect on the early regenerative response. In situ liver 
flushing has a similar effect on the initiation of DNA synthesis to that observed in 
ischaemia. That is, the process is delayed by 24 hrs but is nevertheless complete by 
96 hrs. There is no advantage of any one flushing solution over another in this 
regard. The observed effect cannot be altered by normothermic flushing. The 
technical procedure of liver transplantation has no direct implications in its own 
right on liver regeneration. The effects of ischaemia and liver flushing on liver 
regeneration are not additive when in combination, that is in the stored liver 
allograft. Despite an early delay in the initiation of the process, the regenerative 
response of the partial liver graft is largely unaffected by the multiple insults to 
which it is exposed during experimental transplantation. 
I declare that this dissertation is my own unaided work, except for the assistance 
acknowledged. It is being submitted to the University of Cape Town for the degree 
of Doctor of Philosophy in Surgery. It has not been submitted before for any other 
degree or examination at any other University. 
Douglas Glynn Bolitho 
8 June, 1993 
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one introduction 17. 
1. INTRODUCTION. 
Among the most important problems facing patients with end-stage liver disease 
who qualify for liver transplantation is the shortage of donor organs. 
This has led to the usage of split and reduced liver transplantation in the paediatric 
age group as a means of improving the utilization of donor material. In this 
procedure, the intention is generally to transplant a mass of liver parenchyma that is 
appropriate to the size of the recipient. 
Despite the knowledge that the liver has an unsurpassed ability to regenerate (78), 
and the finding that immunosuppressive drugs enhance this process (149), little 
attempt has yet been made in clinical practise to transplant a small-for-size segment 
of liver into an adult donor (71). This would enable, for example, the matching of a 
single adult donor to two adult recipients (split liver transplant) or a related living 
transplant into an adult recipient. 
Little is known about the regenerative response of reduced liver grafts. The 
regenerative response of full-size liver grafts is delayed in laboratory animals 
(73,290). Knowledge of the proliferative kinetics of reduced liver transplants is of 
cardinal importance to the clinical practice of reduced liver transplantation in adult 
recipients. Furthermore, ischaemia has been noted to be a particular problem in 
reduced liver grafting (21), contributing to greater graft complications. 
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In order to examine more closely the regenerative process, we elected to dissect the 
transplant procedure into its various components: 
1. Warm hepatic ischaemia. 
2. Portal venous occlusion. 
3. Hepatocyte and endothelial damage imposed by flushing with preservation 
solutions. 
4. Storage of the liver. 
5. Technical factors associated with the procedure itself. 
The purpose of the study therefore, was to study whether a normal regenerative 
response occurs in the most abnormal circumstance of liver transplantation. 
Additional insults would take the form of drugs commonly administered to the 
transplant recipient, and rejection of the allograft. The effects of these two factors 
were excluded from the current study. The problem of rejection was avoided by 
utilizing a reduced liver autograft model. 
It seemed that if smaller-than-normal liver transplants regenerated in a near normal 
fashion, then the first major obstacle towards a new era in clinical practise in which 
reduced and split liver grafting can be applied to adults would have been overcome. 
This is already being achieved in renal transplantation, where reliance is placed on 
the ability of the kidney to undergo compensatory hypertrophy in operations using 
small-for-size donor kidneys on adult recipients. The additional advantage of this 
practise in liver transplantation would be the greatly improved utilization of donor 
material. 
one introduction 19. 
A review of current literature in the fields of liver regeneration, ischaernia and 
reduced liver transplantation is presented in the next three chapters to provide a 
background for the development of the hypothesis. 
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2. REVIEW OF HEPATIC REGENERATION. 
An attribute of the liver that continues to fascinate investigators is its latent capacity 
for growth. The hepatocyte is a highly differentiated cell that rarely divides in adult 
humans or animals ( approximately 1 mitosis is seen in 10 000 to 20 000 
hepatocytes). Mature hepatocytes are long-lived and may survive for the adult life of 
the animal. The simple technique of partial hepatectomy, a well tolerated and highly 
reproducible operation, sets in motion a burst of astonishingly rapid growth. This 
growth is precisely regulated, and ceases when the deficit is restored (31). 
Most of the knowledge on hepatocyte growth in vivo derives from studies of the 
regenerating liver after partial hepatectomy in rats. The term regeneration is not 
biologically correct however, in that the growth response induced by the removal of 
liver mass is not truly regenerative. It entails enlargement of the residual lobes 
rather than regrowth of the excised lobes. Restoration of the liver mass occurs by 
the compensatory hyperplasia and hypertrophy of the cells in the remaining lobes 
(32). However, it is a term that is entrenched in the literature and thus it will be 
used throughout the study. 
In addition to pathological types, three types of hepatic growth are generally 
recognized (31). That occurring (a) during normal development, (b) in response to 
altered physiological demands such as pregnancy, and (c) in compensation for lost 
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or damaged tissue. They may be termed (a) developmental, (b) additive and (c) 
reparative respectively (31). Additive and reparative growth are relevant to liver 
regeneration. 
The technique used for partial hepatectomy in rats was described by Higgins and 
Anderson in 1931 (116), and consists of excision of the two main lobes of the liver 
(median and left lateral). It has been shown that in most strains of rats these lobes 
bear a constant relationship to the mass of the whole organ; that is 68% ( + -2%) 
(30). Unless otherwise stated in this thesis therefore, partial hepatectomy (ph) will 
mean resection of this amount of liver tissue. 
Despite intensive study for a period of over 60 years (116), our knowledge of the key 
factors governing regeneration is still incomplete. The topic of liver regeneration 
has been extensively reviewed (78,194,259). In this review emphasis is given to those 
aspects of liver regeneration that are of relevance to this study. 
2.1 MORPHOLOGIC ASPECTS OF REGENERATION. 
The liver mass of partially hepatectomized animals is restored with extraordinary 
rapidity, the residual lobes in normal adult rats nearly doubling in size by 48 hours 
and approaching the original liver mass by seven days (32). After a 24 hour lag 
during which synthesis of new protoplasmic constituents and replication of DNA are 
initiated, mitosis of hepatocytes begins (25). The most pronounced change in gross 
appearance is caused by an extensive temporary infiltration of neutral fat, which 
results in the enlarging remnant taking on a yellowish hue (32). 
Parenchymal liver cells constitute 90 to 95% of the total hepatic cellular volume, 
and 60 to 65% of the cellular population (28). The first morphologic changes to 
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occur after partial hepatectomy take place in this cell population. Within an hour 
after partial hepatectomy, the so-called basophilic bodies of the cytoplasm start to 
disintegrate, beginning in the hepatocytes at the periphery and spreading to the 
centre of the lobule during the next 8 hours. By 2 to 3 hours cytoplasmic inclusion 
bodies or fat vacuoles have begun to accumulate and become increasingly 
conspicuous ( 45). This accumulation of neutral fats is usually attributed to the 
metabolic overload imposed by the circulating lipids upon a reduced cell population 
( 45). Meanwhile, glycogen stores are rapidly depleted, falling to very low levels by 
10 hours and thereafter reappearing gradually. These changes have prompted 
observers to compare the histologic changes in regenerating liver to those of 
starvation (31 ). Cells, nuclei and nucleoli start enlarging by 6 to 12 hours, more than 
doubling in size by 24 hours (281). During this period, the sinusoidal spaces become 
progressively diminished as the enlarged fatty hepatocytes crowd in, distorting the 
normal lobular pattern. Littoral, ductular and connective-tissue cells remain fairly 
unchanged (32). These histologic changes have been examined in detail under the 
electron microscope (278), but discussion of these is beyond the scope of this review. 
After partial hepatectomy, the first clear-cut morphologic evidence that cellular 
proliferation is imminent is the incorporation of nucleic acid precursors into DNA. 
This has been shown by the incorporation of radioactive precursors into DNA by 
autoradiography (105). This results in doubling of the DNA pool, a prerequisite for 
mitosis. After a lag period of about 12 hours, there is a sudden burst of activity, 
reaching a sharp peak at about 20 hours, and followed by a more gradual decline 
(32). The pattern and timing of this response are dependent on the age of the 
animals studied (29), with weanling rats demonstrating an early biphasic response, 
whereas in older rats the initial rise is more gradual and shows a broader and 
slightly later peak (29). 
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Initially, DNA synthesis occurs only in the cells of the outer two-thirds of the lobule, 
although later on this becomes more random (105). This is the area surrounding the 
terminal portal venules and the site of entrance of portal blood into the 
parenchymal unit. Whether this reflects the presence of hepatotrophic substances in 
the portal blood or simply the greater availability of labelled precursors is not 
known (31). 
Peak mitotic activity follows DNA synthetic activity by about 6 to 8 hours (32). 
However, there is not complete synchrony in their division. This is evident from the 
finding that whilst mitosis in any given cell lasts less than 60 minutes ( 67), the 
mitotic peak for the liver as a whole is spread over 12 hours (32). About 20 to 30% 
of normal adult hepatocytes are binucleate, with a high rate of polyploidy. During 
regeneration the proportion of cells with two nuclei drops to 10% and the ploidy 
increases correspondingly (31 ). 
The nonparenchymal cells, unlike the hepatocytes, are uniformly diploid. In their 
response to partial hepatectomy, they lag approximately one day behind the 
hepatocytes with their mitotic peak occurring near the beginning of the third day 
(105). Despite this initial lag, by the eighth day their numbers have increased by the 
same factor (3.37 fold) as the parenchymal cells (31). Of interest is that in the 
regenerating liver the Kupffer cells (littoral cells that exhibit phagocytic activity) are 
doubled in number and demonstrate enhanced phagocytic activity for several 
months (28). The proliferative response however, appears to be more active in the 
hepatocytes than in the nonparenchymal cells. 
Connective tissue is restored slowly, with the collagen content remaining low for 
more than 6 months (31). The cells of the bile ducts do not contribute to the growth 
in the parenchymal cell population during regeneration, nor is there evidence for 
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the existence of a reservoir of "stem cells" from which new hepatocytes could arise 
following partial hepatectomy ( 105). As regeneration approaches completion, the 
normal appearance of the liver lobule is restored, although some changes such as 
polyploidy (28) persist. 
2.2 BIOCHEMICAL EVENTS AFTER HEPATECTOMY. 
2. 2.1 Protein and nucleic acid synthesis. 
Biochemical alterations in the stimulated hepatocyte occur prior to, and 
simultaneous with the abovementioned morphologic changes. These biochemical 
events concern primarily the macromolecules at the core of the regenerative scheme 
- proteins and nucleic acids. Important alterations in protein and RNA formation 
precede the increase in DNA synthesis that occurs 12 to 14 hours after partial 
hepatectomy (31). 
Prior to mitosis, DNA replication occurs in order that each daughter cell receives an 
exact copy of the parental genome. By the process of transcription, information 
contained in the DNA is transferred to several types of RNA: transfer RNA 
(tRNA), messenger RNA (mRNA) and ribosomal RNA (rRNA). These in turn 
participate in translation of the genetic code by providing a template for the 
synthesis of the cellular proteins responsible for cell structure and function. The 
precise details of the process of protein synthesis are beyond the scope of this review 
and can be found in standard biochemical texts (283). 
Instead, this discussion will concentrate upon the timing of the protein synthetic 
response following partial hepatectomy. Deoxyribonucleotides, normally present in 
minute amounts in the liver, increase during the period of 12 to 24 hours after 
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partial hepatectomy (28). Of these, deoxythymidine triphosphate ( dTIP) has the 
distinction of utilizing enzymatic pathways that are unique to its synthesis ie. not 
shared in the synthesis of the other 3 deoxyribonucleotides. During regeneration the 
activities of these enzymes increase (variously from several to 25 fold or more), 
starting at the time that DNA synthesis increases ( 17) and reaching a maximum at 
10 to 20 hours after the DNA synthetic peak (28,79). It has also been found that X-
irradiation before, or shortly after partial hepatectomy, not only blocks DNA 
synthesis but the thymidine kinases do not appear at the expected time (17). These 
results were the first to suggest that the enzymes that phosphorylate thymidine may 
play an important role in the initiation and control of DNA synthesis (12). 
Confirmation of this was provided by the finding that the elevation in thymidine 
kinase corresponded with the incorporation of [14C]thymidine into DNA of 
regenerating rat and pig liver (133). The increase noted in thymidine kinase and 
other deoxyribonucleotide kinases during liver regeneration reflects enhanced 
production of new enzyme molecules, probably via the mechanism of derepression 
(31). The synthesis of thymidine kinase at this time is governed by negative feedback 
control mechanisms (125), in addition to other control mechanisms (194) which will 
be discussed later in detail. There would appear to be many safeguards against 
untimely or inappropriate DNA synthesis. 
DNA polymerase is another enzyme which increases with DNA synthesis (79), 
although differing in that it is active in normal liver. Whilst DNA replication cannot 
occur in its absence, cessation of DNA replication is not related to the decline in 
DNA polymerase activity. This would suggest an accessory, rather than primary role 
in the control of DNA synthesis in regenerating liver (31 ). 
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Puromycin, a protein synthesis inhibitor, will suppress DNA replication in 
regenerating liver, despite the presence of adequate amounts of DNA polymerase 
and the various deoxyribonucleotide kinases (103). It would appear that in addition 
to these enzymes, a necessary prerequisite for DNA synthesis is the synthesis of 
some protein. 
2.2.2 Polyamine metabolism. 
Another metabolic pathway to be stimulated by the regenerative stimulus of partial 
hepatectomy is that concerned with polyamine metabolism. The polyamines 
putrescine, spermidine and spermine have been shown to play vital roles in 
hepatocellular growth and differentiation ( 127). The first step in the synthetic 
pathway to the polyamines is the decarboxylation of ornithine, a reaction catalyzed 
by ornithine decarboxylase (ODC). After partial hepatectomy a marked change in 
ornithine decarboxylase activity occurs during the prereplicative phase of the 
regenerative process (80,250). By the use of competitive inhibitors of ODC (141), 
and the specific irreversible inhibitor alpha-difluoromethylornithine (DFMO) (230), 
investigators demonstrated that ODC inhibition prevented accumulation of 
polyamines and reduced DNA synthesis during the early phase of liver regeneration. 
Luk (172) confirmed these findings and further demonstrated that liver weight gain, 
the ultimate variable of the regeneration process, is inhibited by DFMO. 
Furthermore, the administration of putrescine resulted in a marked reversal of the 
inhibitory effect of DFMO on hepatic DNA synthesis and weight gain (172). A later 
study demonstrated the correlation between hepatic putrescine concentrations and 
restitution of liver mass after hepatectomy (195). Against this however, McGowan 
and Fausto (186) using protein deprived and hypophysectomized rats showed that 
the time course of ODC activity was independent of the onset of DNA replication in 
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experimental situations in which the timing of regeneration had been altered. Taken 
together, these studies would suggest that polyamine metabolism although 
important, may not be pivotal to the regenerative process. 
2.3 REGULATORY MECHANISMS IN HEPATIC REGENERATION. 
In the adult animal the liver is normally in a state of growth arrest. It can however 
be stimulated to grow by a number of means, including exposure to certain toxic 
agents and chemicals, surgical ablation and during the increased metabolic demands 
of pregnancy. 
The regulation of the regenerative process following partial hepatectomy has been 
the focus of much study, and the subject of several excellent reviews (78,166). This 
process must be initiated, and to some degree, regulated by humoral factors for at 
least two reasons (264). Firstly, cell division is seen throughout the entire liver 
remnant and not merely the cut edge, as would occur in simple wound healing. 
Secondly, the process is terminated once the liver remnant has restored itself to the 
size of liver normally present in the animal. The latter would suggest that the 
control mechanism is governed by functional demands. 
Some, but not all of these putative hepatotrophic factors derive from the portal 
splanchnic organs and are therefore more concentrated in portal than peripheral 
blood (26). Much research has been devoted to the study of these substance, as 
reviewed by Starzl and Terblanche (275), whilst more recent study has focused on 
non-portal substances and of hepatocytes in culture ( 194 ). 
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2.3.1 Portal hepatotroplzic factors. 
The regeneration of mammalian liver is largely governed by humoral factors (26). 
The term hepatotrophic has been loosely used to describe substances that result in 
both hyperplasia and hypertrophy of hepatocytes, although liver regeneration is 
largely a hyperplastic process (26). 
Fallowing the observation that portal vein occlusion or diversion led to a decrease 
in the size of the liver deprived of this blood supply, it was postulated that 
regeneration was mediated by portal blood flow through the hepatic remnant 
following partial hepatectomy (177). This was the basis of the vascular theory and 
was based on studies in dogs using the so-called Eck fistula (55,177). An Eck fistula 
consists of a side to side portocaval shunt with ligation of the distal portal vein, so 
converting it into a functional end to side fistula. 
However, despite the atrophy of the liver consequent to portal venous diversion in 
the Eck fistula model, there appeared to be surprisingly little impairment of 
regenerative capacity, although the process was somewhat delayed (299). This 
provoked the question of whether the observed atrophy was due to deprivation of 
the constituents of portal blood, or merely a non-specific effect of diminished blood 
supply. 
This dilemma prompted Child et al ( 54) to deprive the hepatic remnant of portal 
blood and in its place to substitute vena caval blood. This was achieved by 
portocaval transposition in a series of experiments on dogs. Under these 
circumstances the liver enlarged. From this it was concluded that portal blood was 
probably not specifically required for liver regeneration. This was later confirmed by 
Weinbren in a further study involving portal diversion and partial hepatectomy 
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(298). In this study the liver remnant, though deprived of portal blood and 
undergoing atrophy, exhibited an increase in mitoses. These findings have been 
confirmed in the orthotopic liver transplant by Sumimoto et al, who showed no 
evidence of hepatic atrophy following portocaval transposition in rat liver allografts 
(287). 
It appears then that the liver can regenerate in the presence of diminished blood 
flow, and that portal diversion produces superimposed atrophy. This would suggest 
no more than a permissive role for bloodflow in liver regeneration. 
2.3.1.1 Insulin and glucagon. 
The role of insulin in liver growth was first demonstrated by Younger et al (305), 
who showed liver growth following insulin administration in rats rendered diabetic 
by the administration of alloxan. Subsequently in a series of experiments involving 
so-called 'splanchnic division', Starzl (272,273,274) demonstrated the beneficial role 
of insulin to the regenerating liver. In these experiments, the pancreatic venous 
effluent was routed to the right lobes whereas the nutrient-rich venous blood from 
the intestine drained into the left lobes of the liver. The response to partial 
hepatectorny was assessed on both sides and found to be greater on the side 
receiving pancreatic blood. This advantage was lost following the administration of 
alloxan. This not only demonstrated the hepatotrophic effect of portal venous blood 
in a model in which differences in bloodflow had been excluded, but also implicated 
insulin as a responsible factor. It was however stated that other potentially 
hepatotrophic factors in portal venous blood may have been present. 
This led Bucher and Swaffield to study hepatic DNA synthesis in eviscerated, 
partially hepatectomized rats maintained on a nutrient infusion (33,34 ). They found 
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that regenerative activity was both delayed and diminished, and did not respond to 
the infusion of insulin or glucagon alone. When both of these hormones were 
infused however, a synergistic effect was noted with DNA synthetic activity being 
restored to that of partially hepatectomized controls. 
Following partial hepatectomy, portal and systemic levels of insulin are diminished, 
whilst glucagon levels are elevated (153,205). The exact role for these two hormones 
has probably not been adequately explained, but powerful evidence for a direct 
action comes from the more recent finding that the stimulation of DNA synthesis in 
hepatocyte culture by epidermal growth factor is enhanced by the addition of insulin 
and to a lesser extent glucagon (245). However, insulin does not stimulate 
hepatocyte proliferation in culture despite potent trophic effects (194). 
In summary, there is convincing evidence that insulin and glucagon play a 
permissive role in hepatocyte DNA synthesis and liver regeneration. There is no 
evidence however that these substances have any direct mitogenic effects on the 
liver. 
2.3.1.2 Nutritional factors. 
Apart from insulin, glucagon and possible other hormones in the portal circulation, 
the other constituents of portal blood that are of importance in hepatic regeneration 
are the nutrients absorbed from the intestine. 
Starvation for 48 hours delays and diminishes the regenerative response, but does 
not completely abolish it (200,280). The effect of pure protein deprivation on the 
other hand has been variously reported to have either no effect on DNA synthesis 
(200), or to result in a decrease (265). DNA synthesis in partially hepatectomized 
rats fed amino acids and branched-chain amino acids is diminished (152). The 
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infusion of glucose has been demonstrated to inhibit the onset of hepatic 
regeneration (117). 
Absolute clarity on the effects of nutritional factors in hepatic regeneration has 
therefore not been obtained, however it is unlikely that they play a central role in 
the regulation of the regenerative process. 
2.3.2 Non-portal factors. 
While portal factors have been shown to influence regeneration, they may not 
initiate this process but merely play a permissive role. 
The finding that injection of regenerating liver homogenate resulted in the increase 
in hepatic mitotic activity in a second animal (188,291,296), suggested that the 
initiation of the regenerative process may begin in the liver itself. This concept has 
been more recently examined by Levi (168) and Kahn (137). 
Evidence for the implication of circulating non-portal factors in regeneration came 
from cross-circulation experiments. Regenerative activity was increased in the intact 
liver of the unresected partner of a pair of parabiotic rats after partial hepatectomy 
in the parabiotic twin (27). Also, mitotic activity was increased in small heterotopic 
liver autografts in partially hepatectomized animals (167,264). The same 
phenomenon occured when isolated hepatocytes were transplanted into a partially 
hepatectomized animal (128). 
The stimulatory effect of serum from animals with a regenerating liver was first 
demonstrated in hepatocyte culture in 1952 (100). This heralded the onset of the 
new era of in vitro investigation of the regenerative process. 
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Important progress in defining the key regulatory factors has been achieved by using 
hepatocyte cultures in serum-free media. This is achieved by the perfusion of rat 
liver with collagenase (258). The technical details of this method are beyond the 
scope of this review, however. It is nevertheless of interest to note that an essential 
prerequisite for hepatocyte cell culture is insulin. Despite having strong trophic 
effects, it does not itself stimulate DNA synthesis in chemically defined media (194). 
Using hepatocyte culture, it was possible to show that a few specific polypeptide 
growth hormones could stimulate DNA synthesis. These factors can be classified as 
follows (194): 
1. Complete hepatocyte mitogens. 
2. Growth inhibitors. 
3. Incomplete mitogens or comitogenic substances. 
2.3.2.1 Complete hepatocyte mitogens. 
These are defined as substances that are able to initiate DNA synthesis in serum-
free hepatocyte culture (194). Substances capable of this action include the 
following: 
Epidermal growth factor (EGF). 
Epidermal growth factor is a polypeptide of 53 amino acids (284) that stimulates the 
proliferation of hepatocytes in vitro (187) and in vivo (35). It exerts its effects via a 
specific cell membrane receptor which it shares with transforming growth factor 
alpha (TGF alpha) (284). After binding of EGF or TGF alpha to the cell 
membrane receptor rapid autophosphorylation and dimerization occurs (284 ). EGF 
is the prototype mitotic stimulator which stimulates division of hepatocytes amongst 
other epithelial cells ( 187). It was the first substance shown to have this effect on 
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hepatocytes in culture, inducing thymidine labelling indices of 60-80% (194). Insulin 
is not essential for EGF-stimulated mitogenesis, but is necessary if the full 
magnitude of the response is to be produced (86). The peak of EGF-mediated DNA 
synthesis does not occur until 48 to 72 hours (297), in contrast to the 24 hour peak 
normally witnessed during liver regeneration (29). This delay has not been 
explained, although it may represent repair processes following the action of 
collagenase used to prepare cells for tissue culture, and cellular adaptation to the in 
vitro environment (194). EGF mediated stimulation of DNA synthesis in hepatocyte 
culture usually results in 2 to 3 cycles of DNA synthesis and cell division after which 
the process stops (194). 
EGF receptors decrease in primary hepatocyte culture (129), and the affinity of 
remaining receptors for EGF diminishes (303). There are two types of EGF 
receptor: high affinity (ha) and low affinity (la) (284). The ha receptors are lost 
following hepatocyte isolation, whereas the la receptors persist. The la receptors are 
the only receptors present when the mitogenic response is stimulated. This has led 
to the hypothesis that the la receptor is the true mitogenic EGF receptor and the ha 
receptor merely serves to deny access to the mitogenic receptors at a time when 
mitogenesis is not appropriate (303). 
The fate of the EGF receptor complex has been studied in vivo (242). One fraction 
is taken up by the nucleus and the other secreted into the bile (242). The 
significance of the translocation of this nuclear fraction is unknown. 
EGF stimulates other hepatocyte functions such as protein synthesis and amino acid 
transport (284). TGF beta inhibits the EGF-mediated DNA synthesis but not 
protein synthesis (119). 
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Although EGF has been used as the prototype mitogen for hepatocytes its role in 
regeneration is still not clear (194). Although no changes in serum levels of EGF 
have been shown following partial hepatectomy, there is a decline in the number of 
EGF receptors (249). Saturation of the remaining binding sites may account for the 
decreased expression of EGF receptors after partial hepatectomy, since binding 
sites are reduced by 2/3 whilst serum levels of EGF are constant. EGF is produced 
in the Briinners glands in the duodenum (284 ), and hence is not affected by liver 
resection. An alternate explanation may lie in the fact that transforming growth 
factor alpha (TGF alpha) and EGF share the same receptor on the hepatocyte 
membrane (190). Increased production of TGF alpha by hepatocytes, such as occurs 
during liver regeneration, might therefore account for this effect. A decline in EGF 
receptor mRNA production occurs, which would account for diminished receptor 
synthesis and resultant decreased EGF receptor binding (129). 
The mitogenic effects of EGF are inhibited by TGF beta (20). This finding has led 
to the hypothesis that TGF beta forms part of a paracrine control mechanism that 
limits cell proliferation. 
Both in vivo and in vitro, noradrenaline has been shown to down-regulate the EGF 
receptor in a heterologous manner ( 64 ). It is via the alpha-1 receptor that this effect 
is mediated ( 62). Catecholamine levels are elevated after partial hepatectomy in the 
rat ( 62). Surgical hepatic denervation reduced incorporation of [3H] thymidine into 
liver DNA during the first 24 hours in partially hepatectomized rat livers (62). This 
would implicate catecholamines, acting via the alpha-1 receptor, as playing an 
important role in the early regenerative response ( 64 ). This factor may be of 
cardinal importance in the current study. 
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Many questions relating to whether EGF is in fact the naturally occurring mitogen 
that induces the changes associated with regeneration have yet to be answered. 
However, it is the only factor which after injection into laboratory animals with 
intact livers results in increased DNA synthesis (36). 
Transforming growth factor-alpha (TGF alpha). 
Recent work has shown regenerating hepatocytes produce TGF alpha (190). TGF 
alpha shares the same receptor as EGF (190) and has been found to be a more 
powerful mitogen than EGF in hepatocyte culture (190). An increase in TGF alpha 
concentration has been shown in regenerating liver (190). Being a complete 
hepatocyte mitogen, TGF alpha may constitute an autocrine mediator whereby 
hepatocytes initiate DNA synthesis. The mitogenic effects of TGF alpha are (like 
EGF) inhibited by TGF beta (20). TGF beta is derived from nonparenchymal liver 
cells, and its inhibitory effects may therefore form part of a paracrine mechanism of 
growth inhibition (20). 
Gene expression changes may represent a priming state in which cells are prepared 
for division but are not yet committed to it (194) (see page 42). Subsequent TGF 
alpha synthesis may then be the critical step prior to initiation of DNA synthesis. 
Increased levels of TGF alpha occur after 8 hrs and peak after 24 hrs with a 
subsequent smaller peak at 72 hrs ( 194 ). The kinetics of TGF alpha synthesis 
therefore parallel those of normal DNA synthesis. 
Hepatocyte growth factor (HGF) or Hepatopoeitin A (HPTA). 
This substance of 100 000 kDa was found in the serum of hepatectomized rats and 
described as hepatopoeitin A by Michaelopoulos et al in 1983 (192,193). In 1984 
Nakamura isolated a similar substance and called it hepatotropin (206). In 1986 
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Gohda et al (101) identified a factor in patients with fulminant hepatic failure and 
termed it human HGF. A substance with a heterodimer structure was identified by 
Nakamura in 1987 from rat platelets and called hepatocyte growth factor (HGF) 
(207). Most recent work suggests these (HPT A and HGF) are the identical 
molecule, with small differences due to species variation (199,306). 
The molecular structure of HPT A/HGF has recently been described (307). It is a 
heterodimer consisting of two chains, one of 70 000 kDa and another of 35 000 kDa, 
held together by 2 disulphide bonds. It is 10 times more potent than EGF in terms 
of nuclear labelling index in hepatocyte culture. Furthermore, its effects are additive 
to, and distinct from, those of EGF (209). 
Like EGF, the rnitogenic effect of HPTA/HGF is inhibited by TGF beta (194), 
although it does not share the same receptor as EGF (307). The major tissue 
sources of HPTA/HGF are the pancreas, brain, the interfollicular cells of the 
thyroid and the Briinners glands in the duodenum (194). Secretion of HPTA/HGF 
by the pancreas and duodenum suggest its presence in the portal circulation where it 
would be continually available to the liver (194). 
Heparin binding growth factor (HBGF-1). 
This heparin-binding growth factor, like HPTA/HGF, stimulates hepatocyte DNA 
synthesis. Unlike HPT A/HGF it is totally inactive in the absence of heparin, and by 
definition therefore not a complete rnitogen. Hepatic gene expression of HBGF-1 
precedes the expression of the TGF alpha gene (145). This suggests that HBGF-1 
may provide the autocrine stimulus that initiates regeneration, prior or simultaneous 
to the EGF /TGF alpha mediated stimulus. It is synthesized by regenerating 
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hepatocytes, with the peak of secretion occurring at the time of peak DNA synthesis 
(145). 
Hepatic stimulatory substance (HSS). 
Previous descriptions of this substance have referred to crude cytoplasmic extracts 
obtained from regenerating liver (137,168,188,291,296). More recently however, a 
hepatic stimulator substance has been characterized independently by Francavilla 
(87), LaBreque (157) and Fleig (83). The substance is described as a factor of 
approximately 16 000 kDa molecular weight which results in enhanced DNA 
synthesis in rat hepatocytes in vivo. It is extracted from neonatal and regenerating 
livers. Like HBGF-1, HSS is not a complete mitogen for hepatocytes in culture, as it 
also requires heparin for activity. 
Hepatopoeitin B (HPTB). 
This is the name assigned to the other identified factor isolated from the serum of 
hepatectomized rats, other than HPTA (194). A complete hepatocyte mitogen, it 
acts synergistically with both EGF and HPTA. Little more is known about it. 
2.3.2.2 Growth inhibitors. 
These substances have been defined in primary culture, based on their ability to 
inhibit EGF-mediated mitogenesis. Three have been identified. 
Transforming growth factor beta (TGF beta). 
This is a group of three cytokines, with reference usually being made to TGF beta 1. 
This is a molecule of 26 000 kDa, which is elaborated by activated Kupffer cells or 
macrophages. TGF beta has been associated with a number of in vivo functions 
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including wound healing and the inhibition of mesenchyme-derived cell 
proliferation (271). 
TGF beta inhibits the mitogenic effects of EGF and TGF alpha on hepatocytes ( 48). 
The addition of TGF beta to hepatocyte culture inhibited the peak of EGF-
mediated DNA synthesis (at 72 hrs) (48). The mechanism whereby TGF beta exerts 
this effect is poorly understood. TGF beta has no effect on EGF receptor binding or 
EGF receptor autophosphorylation (252). In vivo, TGF beta mRNA production is 
first detected in nonparenchymal cells 4 hours after partial hepatectomy, thereafter 
peaking sharply at 72 hours. Levels remain high for more than 96 hrs (20,49). 
Russell (253) demonstrated an inhibition of DNA synthesis following partial 
hepatectomy by the administration of TGF beta at various times before and shortly 
after the procedure. However, repeated and stronger doses of TGF beta failed to 
obliterate the peak which occurred at 72 hours after partial hepatectomy. 
Interleukin 1 beta. 
It was recently shown that interleukin 1 beta inhibits hepatocyte proliferation, 
although the degree of inhibition is not as great as with TGF beta (208). Similar but 
lesser effects have been observed with Interleukin 6. Interleukin 1 beta is known for 
its effects in redirecting protein synthesis in liver cells toward acute phase reactants 
(208). Its inhibitory effect on DNA synthesis might reflect a reprogramming of 
hepatocyte gene expression and DNA synthesis toward acute phase protein synthesis 
in preference to synthetic processes leading to hepatocyte proliferation. This is a 
postulated mechanism for the delayed DNA synthesis in partially hepatectomized 
animals in which a simultaneous inflammatory stimulus is produced (11). 
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Hepatocyte proliferation inhibitor. 
This protein, isolated from normal rat liver, was found to inhibit DNA synthesis 
specifically and reversibly in normal hepatocytes. It is distinct from TGF beta as no 
inhibition was produced in hepatocyte culture with the addition of anti-TGF beta 
antibodies (121). 
2.3.2.3 Honnones (comitogens). 
These have been defined by Michalopoulos (194) as substances that affect growth 
positively in an indirect manner. They all have the following properties: 
a) enhancement of the mitogenic effects of growth stimulators (EGF,TGF 
alpha). 
b) decrease the inhibitory effect of growth inhibitors. 
c) no direct mitogenic effects of their own in culture (194). 
The nett effect of these substances is to tilt the balance in favour of those factors 
stimulating proliferation. 
Noradrenaline. 
A role for the sympathetic nervous system, noradrenaline and the alpha-1 
adrenergic receptor in liver regeneration has been described ( 62). Blockade of the 
alpha-1 receptor by prazosin abolished the 24 hour DNA synthetic peak in rats in 
vivo ( 62). Similar effects were seen with hepatic denervation. The alpha-1 
adrenergic receptor has been shown to mediate the catecholamine effect, by 
downregulation of the EGF receptor and enhanced EGF mitogenic effects (64). A 
similar decrease in EGF receptors and enhanced responsiveness to EGF is seen 
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during liver regeneration (86). Noradrenaline also decreases the inhibitory effect 
that TGF beta has on hepatocyte mitogenesis in culture (119). If hepatocytes from 
liver 12-16 hours after partial hepatectomy are cultured in the presence of EGF and 
TGF beta, then noradrenaline greatly enhances their effect on rnitogenesis (194 ). 
There is thus clear evidence that the alpha-1 adrenergic receptor is essential during 
the early regenerative response. 
It appears that the catecholamine effect is mediated by a receptor distinct from both 
the EGF /TGF alpha and the TGF beta receptor. The alpha-1 receptor is linked to a 
recently described G protein ( 111) which stimulates increased activity of 
phosphatidylinositol dip hosp hate (PIP2) phosphodiesterase. Stimulation of the 
alpha-1 receptor results in greater breakdown of PIP2 with a resultant accumulation 
of mediators which trigger a cascade of intracellular events, including the activation 
of protein kinase C and release of intracellular calcium stores (77). Phenomena 
described as occurring very early after partial hepatectomy include membrane 
hyperpolarization, glycogenolysis, and an increase in diacylglycerols ( 119). All of 
these are classically mediated by receptors that result in mobilization of intracellular 
calcium reserves. 
Catecholamines increase sharply in the serum following partial hepatectomy, 
perhaps due to the removal of 68% of monoarnine oxidase activity (with the 
resected liver) (86). These catecholamines are a potential source of stimulation to 
the alpha-1 receptor (86). 
Vasopressin and angiotensin. 
Liver regeneration is impaired in strains of rats that are congenitally deficient in 
vasopressin production (251). Both vasopressin and angiotensin act via receptors 
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that enhance PIP2 turnover and stimulate glycogenolysis (77). Vasopressin is 
secreted by the sympathetic nerves of the liver along with noradrenaline (90). Both 
noradrenaline and vasopressin may therefore be involved in the previously observed 
effects of the sympathetic nervous system on liver regeneration. Vasopressin and 
angiotensin 2 have a similar intracellular cascade following the activation of their 
respective receptors. 
Oestrogens. 
Substantial evidence exists for the role of oestrogens in liver regeneration (85,90). 
Oestrogen levels increase after partial hepatectomy, peaking at 24 to 48 hours. 
Testosterone levels show a corresponding decrease. Similarly, oestrogen receptors 
increase after partial hepatectomy, whilst androgen receptors decrease (85). The 
evidence for the direct involvement of oestrogen in regeneration comes from the 
finding that when added to primary hepatocyte cultures with serum or EGF, 
oestrogen enhances the mitogenic effect of EGF (262). Oestrogen is also known to 
promote hepatic tumorigenesis (194). 
Corticosteroids. 
Both adrenocorticotrophic hormone (ACTH) and glucocorticoids have been shown 
to induce liver enlargement. This is almost entirely due to cellular hypertrophy (26). 
However, glucocorticoids in pharmacologic doses actually tend to retard or delay 
the normal proliferation of liver that occurs following partial hepatectomy (26). 
Surgical stress significantly accelerates the rate of DNA synthesis following partial 
hepatectomy (201). It would appear that the effect of these hormones on liver 
regeneration cannot be seen in isolation. 
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The clue to the role of corticosteroids in liver regeneration may lie in the regulation 
of circadian rhythm. The mitotic activity of regenerating rat liver is maximal during 
the day (309). Barbason et al have shown that in rats hepatectomized in the late 
afternoon or evening the peak mitotic activity occurs both later and is of greater 
magnitude than after partial hepatectomy in the morning (310). Furthermore, 
hepatocellular proliferation may be mutually exclusive of normal hepatocellular 
function in the regenerating rat liver (309). Barbason and Van Cantfort (309) have 
postulated the derepression of genes responsible for cellular proliferation following 
partial hepatectomy, with simultaneous repression of genes governing normal 
hepatic synthetic and degradative function. Corticosteroid hormones, themselves 
secreted in a circadian rhythm, may therefore form part of the mechanism 
controlling expression of enzymes and proteins involved in hepatocellular 
proliferation. 
2.3.3 Proto-oncogene expression. 
Proto-oncogenes can be assumed to be normal genes which are expressed during 
periods of normal and neoplastic growth. Proto-oncogene expression is a 
phenomenon occurring as part of the normal regenerative response (78). There is 
sufficient evidence to suggest that they appear to be essential for normal growth. 
The expression of these genes and their products after partial hepatectomy is 
specific, sequential and highly regulated, with each oncogene being expressed at 
specific times after partial hepatectomy (132). Changes have been shown in the c-
fos, c-myc,p53, and the ras family of proto-oncogenes (132). These genes may be 
primary regulators of key events in the cell cycle (78). 
Notwithstanding the existing uncertainties in the current understanding of the 
regenerative process, it is possible to use proto-oncogene expression to identify 
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different stages of regeneration (78). In the first stage, identified by the expression 
of c-fos and c-myc, the cell becomes capable of proliferating if the appropriate 
inducer is present. The 'primed' hepatocytes then progress to the second stage which 
is characterized by the expression of the p53 and c-ras proto-oncogenes. It is 
proposed that the autocrine and paracrine mechanisms previously discussed are 
responsible for regulation of this stage (78). This would imply that the regenerating 
hepatocytes are largely responsible for their own growth. The rapidity of the 
expression of the c-fos proto-oncogene (0 to 4 hours) suggests that priming starts 
almost immediately after partial hepatectomy. 
2.3.4 Endotoxin and hepatic regeneration. 
Endotoxin is the lipopolysaccharide (LPS) outer wall of gram-negative bacteria and 
is present in large quantities in the gut from death of bacteria and release from 
intact organisms. The normal transit of this macromolecule from the gut into the 
portal circulation in small quantities has been demonstrated (126). The mechanism 
of this absorption has been demonstrated in intestinal ischaemia to be due 
lymphatic absorption from the peritoneal cavity (216). 
The administration of exogenous endotoxin has been shown to significantly enhance 
DNA synthesis (266). Cornell (58) showed that pretreatment with endotoxin 24 
hours prior to partial hepatectomy accelerated DNA synthesis. Systemic 
hyperglucagonaemia and hyperinsulinaemia as well as an elevation in EGF were 
associated with this response. Systemic gut-derived endotoxaemia has been 
demonstrated following partial hepatectomy in rats (58). Moreover, restriction of 
gut-derived endotoxin by decontamination of the gut diminished DNA synthesis and 
two hepatic regeneration 44. 
the alterations in plasma insulin and glucagon levels following partial hepatectomy 
(60). 
There is thus a striking similarity between the release of putative hepatotrophic 
factors following systemic endotoxaemia caused by exogenous endotoxin 
administration, and by endogenous endotoxin release by the gut after partial 
hepatectomy (61). This would suggest a direct role for endotoxin in normal 
hepatocyte proliferation following partial hepatectomy. Endotoxin is one of the 
activators of the monocyte-macrophage effector system which by the release of 
potent cytokines cause a variety of tissue effects. The range of cytokines released by 
endotoxin-activated Kupffer cells includes prostaglandin-E2, which has been 
implicated in the regulation of the regenerative process ( 43). 
It would appear that in the case of regeneration that endotoxin may be inextricably 
linked to normal physiological processes. Perhaps the role of gut-derived endotoxin 
in normal physiology is to stimulate the secretion of hepatotrophic factors for liver 
regeneration through as yet undefined pathways. By the activation of Kupffer cells, 
endotoxin may provide a paracrine trigger for the initiation of the regenerative 
response. 
2.4 THE EVALUATION OF THE REGENERATIVE RESPONSE. 
Despite the simplicity of the model by which regeneration is initiated by partial 
hepatectomy, accurate measurement of the ensuing process has proven to be 
evasive. Most investigators have relied on liver weight, the estimation of mitotic 
activity by histologic or autoradiographic methods, measurement of DNA synthesis 
and other indirect markers of the regenerative process (68). Unfortunately each of 
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these parameters is subject to recognized errors and inconsistencies. The best 
measure of hepatic regeneration would be some metabolite, cytokine or hormone 
which is centrally involved in the regulation of liver growth. Until the components of 
the hypothetical regulatory cycle have been comprehensively described, this will not 
be forthcoming. Parameters in current use reflecting cell growth and division can 
serve as an assay of the regenerative process, provided their limitations are borne in 
mind. Such parameters should be easily and reproducibly assayed and should not be 
influenced artefactually by an experimental manipulation. 
We have elected to utilize four independent parameters as indices of liver 
regeneration and DNA synthesis. These parameters are: 
a) Mitotic index. 
b) Thymidine kinase. 
c) Ornithine decarboxylase. 
d) Liver to body mass ratio. 
For details of the techniques involved, the reader is referred to page 77. 
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2.5 SUMMARY. 
1. The liver has the inherent capacity to regulate its own size. 
2. Regulation of liver growth is dependent on both intrahepatic and humoral 
factors. 
3. The exact role of circulating hormonal factors remains unknown, mainly due 
to the complexity of changes occurring in vivo. 
4. From studies in hepatocyte culture, TGF alpha and TGF beta and HGF have 
emerged as growth factors of major importance. TGF alpha is an autocrine 
factor produced by hepatocytes that results in enhanced DNA synthesis. TGF 
beta is produced by nonparenchymal cells and functions as a paracrine signal 
to terminate hepatocyte proliferation. 
5. The triggering of hepatocyte proliferation involves the priming of 
hepatocytes, a process closely related to the expression of proto-oncogenes. 
6. Endotoxin is a possible mediator of the normal regenerative process, by a 
paracrine mechanism. 
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3. REVIEW OF HEPATIC ISCHAEMIA. 
The temporary interruption of hepatic bloodflow is obligatory in hepatic 
transplantation, and is sometimes desirable in the management of acute hepatic 
trauma and hepatic malignancy. The purpose of this review is to summarize the 
existing knowledge on the effects of warm hepatic ischaernia. 
3.1 HEPATIC ISCHAEMIAAND REGENERATION. 
The question of hepatic regeneration following an ischaernic insult has been 
addressed by MacKenzie et al ( 173). In this study, total hepatic vascular occlusion 
with portal decompression and subsequent partial hepatectomy were performed in 
the canine model. The liver mass was studied at the time of sacrifice 6 weeks 
postoperatively, at which time a 98% return to normal weight was demonstrated. No 
other parameters of liver regeneration were however studied, and at no other time 
periods. More recently, the effect of warm ischaemia on liver regeneration has been 
examined in rats (96), with depression of hepatocyte regeneration noted upon 
exposure to ischaemia of up to 25 mins duration. 
Given the burgeoning interest in reduced and split liver transplantation, and in 
hepatic resection using total hepatic vascular isolation, a clear need has arisen to 
examine more closely the effects of hepatic ischaemia on liver regeneration. 
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3.2 HISTORICAL OVERVIEW. 
Consideration of the tolerance of the liver to ischaemia has been the subject of 
study for those whose interest has been in the fields of hepatic resection and liver 
transplantation for almost a century (233). 
Early studies addressed the question of mortality associated with hepatic ischaemia, 
and the maximum duration of occlusion of the porta hepatis. Studies on dogs 
showed a high mortality when the duration of hepatic ischaemia was extended 
beyond 20 minutes (240). Occlusion of the porta hepatis and the superior 
mesenteric artery for 60 minutes' duration resulted in 100% mortality. The same 
manoeuvre lasting for 30 minutes caused the death of 7 out of 9 dogs, whilst there 
was no mortality associated with 20 minutes' hepatic ischaemia. The classical 
maximum duration of hepatic ischaemia was derived from these observations. The 
demonstration of transient hyperkalaemia following periods of inflow occlusion 
served to strengthen the argument of those who believed that further prolongation 
of hepatic ischaemia was possible (110, 311 ). 
Jolly and Foster later showed that extension of the ischaemic period to 49 minutes 
was possible in dogs provided adequate splanchnic decompression was employed 
(131). This was provided by means of a side-side portocaval shunt. In a subsequent 
study, improved mortality ( 60%) following 75 minutes of ischaemia and partial 
hepatectomy was demonstrated in dogs in which adequate splanchnic 
decompression was employed (173). These studies appeared to provide strong 
evidence that the mortality associated with hepatic inflow stasis in dogs was more a 
function of the adequacy of splanchnic decompression than hepatic ischaemia per se. 
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It was perhaps bad fortune that dogs were used for the initial studies of hepatic 
ischaemia. The canine hepatic veins have well-developed sphincters which when 
constricted contribute to "outflow block" in response to acidosis, hypothermia or 
excessive handling (202). This phenomenon has not been reported in man or in the 
pig. Secondly, it was shown that the canine liver tends to be colonized by Clostridial 
organisms following ischaemia (52). The validity of the canine model and the 
applicability of these observations to the clinical situation was therefore challenged. 
Subsequent studies in pigs showed tolerance of longer periods of ischaemia 
(8,81,112,135,214) The maximum safe period was therefore progressively extended 
to 35 minutes (8), and subsequently to 120 minutes (214). 
Subsequent work even challenged the belief that hepatic ischaemia was deleterious 
at all (81), arguing that deprivation of portal venous blood has the concomitant 
advantage of reducing the metabolic requirements associated with the passage of 
portal blood. Furthermore, the liver has a high concentration of antioxidants and 
free radical scavengers, a high oxygen extraction ratio, and the ability to 
autoregulate its own bloodflow (81). These factors all contribute to an extraordinary 
hepatic resistance to ischaemic insult. An additional protective factor is the 
inadvertent hypothermia that occurs during laparotomy. This would serve to 
diminish the hepatic metabolic rate and improve the ischaemic tolerance of the 
liver. 
Certainly it would appear that the liver is uniquely equipped to deal with 
deprivation of its blood supply. Furthermore, the tolerance of the liver to ischaemia 
is largely dependent on the method of splanchnic decompression employed as well 
as on the species studied. In this regard it is unfortunate that few satisfactory studies 
have been performed on non-human primates (118). Importantly, the human liver 
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tolerates ischaemia well due to the presence of well-developed portosystemic 
collateral channels. From clinical studies ( 122) and subsequent experimental studies 
(112,214) it has been suggested that the classical maximum time for porta hepatis 
occlusion be extended to 1 hour. The liver's tolerance to ischaemia is again being 
tested in the clinical practise of hepatic inflow occlusion at the time of hepatic 
resection (292). 
3.3 EFFECTS OF PORTAL VEIN OCCLUSION. 
The effect of acute ligation of the portal vein is a topic of recurring interest. It has 
been demonstrated to be fatal in a number of animals (7,130). The cause of this 
mortality has been an area of some controversy. Claude Bernard in 1877 postulated 
as follows: "The mechanism of death is easy to understand. All the blood tends to 
accumulate in the vessels of the intestine. The brain and other organs become 
exsanguinated and the animal dies, in fact, of anaemia" (10). Schiff, by tying the 
portal vein of the cat, claimed to suppress biliary secretion, and he considered that 
death was due to a toxic substance in the portal blood which the liver destroyed to 
form the elements of bile (257). 
Thus it appeared that two main theories were popularized to explain the high 
mortality associated with portal venous occlusion: the first, ( of Bernard) suggested it 
to be due to splanchnic pooling of blood with death ensuing from hypovolaemic 
shock, whilst the second ( of Schiff) proposed that an undesignated toxin produced in 
the gut resulted in the death of the animal. Several studies set out to prove or 
disprove these two theories, using a variety of animal models and with conflicting 
results. These have been reviewed by Johnstone (130). 
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A much more recent study demonstrated impaired Kupffer cell function following 
portal vein occlusion ( 118), and further suggested that failure of the 
reticuloendothelial system to neutralize endotoxin released from the gut may 
account for increased mortality. Portal venous occlusion for 30 minutes resulted in 
the appearance of endotoxin in the portal and systemic circulation (215). The 
presence of gram-negative bacteria has been shown in both the portal and systemic 
blood in the calf following occlusion of its portal vein (7). It was noted in the study 
of Okay et al that all animals in which portal endotoxaemia was demonstrated 
following portal venous occlusion, also had systemic endotoxaemia (215). This 
suggested a decreased clearance of endotoxin by the liver. This diminution in 
phagocytic activity by Kupffer cells was documented in portal vein-occluded rats 
(215) as had been demonstrated in non-human primates (118). An element of this 
post-occlusive depression was accounted for by the known reticuloendothelial 
depressive properties of endotoxin (260). However, it is unlikely to play a major role 
as phagocytic depression has also been shown in gnotobiotic rats (215). It would 
appear that in addition to the venous pooling with resultant hypotension that 
characterizes portal venous occlusion, an added insult to the host occurs in the form 
of portal and systemic endotoxaemia, as well as reticuloendothelial depression. 
These composite events may well be contributory to the effects of acute temporary 
portal venous occlusion. The role of endotoxin in the hepatic regenerative response 
has been previously discussed on page 43. 
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3.4 HAEMODYNAMIC EFFECTS OF HEPATIC ISCHAEMIA. 
Hypotension is a universal phenomenon following hepatic inflow occlusion. The 
pathophysiology of this hypotension has been the focus of much study. From an 
early stage a biphasic response to hepatic inflow occlusion has been noted (4,131). 
Early hypotension. 
Immediately following the application of clamps to the portal vein and hepatic 
artery of dogs, there is a profound fall in blood pressure (4,131). A simple 
haemodynamic explanation for this, as originally proposed by Bernard (10) has 
gained universal acceptance. Following occlusion of the portal vein and the 
concomitant splanchnic pooling of blood, there is a diminution in venous return. 
This results in decreased right atrial filling with the decline in cardiac output 
manifesting as systemic hypotension. Following the initial depression, the blood 
pressure tends to remain constant during the ischaemic period due to circulatory 
compensatory mechanisms ( 131 ). 
Late hypotension. 
Jolly (131) reported a profound fall in blood pressure on release of the portal vein 
and inferior vena cava (IVC) clamps after a 49 minute period of clamping, despite 
employing a side-to-side portocaval shunt for portal venous decompression. This 
followed a brief period of normotension. The observed hypotension was initially 
sensitive to vasopressors, but subsequently became increasingly resistant to their 
action. This biphasic blood pressure response was also observed by Backlund who 
noted the hypotension to be associated with bradycardia ( 4 ). The inappropriate 
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bradycardia suggested that a purely haemodynamic aetiology for the hypotension 
may be an oversimplification. 
Buckberg attributed the hypotension to sequestration of blood in the ischaemic liver 
and the elaboration of the so-called vasodepressor material (VDM) (37). This 
substance was thought to be produced by the anoxic liver at the time of reperfusion. 
This proposal was based on the finding that aliquots of hepatic venous blood 
collected from ischaemic dog livers following revascularization resulted in profound 
shock when infused into dogs with hepatic inflow occlusion (37). Hypotension did 
not result when this blood was infused into dogs without hepatic inflow occlusion. 
This prompted the conclusion that normal liver function was necessary to remove 
the vasodepressor material from the circulation. 
Other possible aetiologic factors for the unexplained hypotension were reported as 
hyperkalaernia (110,279), acidosis (37) and bacterial factors (52). However, no 
reversal of the hypotension was observed in subsequent studies in which pH and 
potassium levels were corrected ( 4,131). It was however shown that acidosis does 
increase hepatic vascular resistance in dogs with resultant hepatic congestion (37). 
Hepatic congestion would therefore appear to be an epi-phenomenon rather than a 
cause of hypotension. 
The possibility of bacterial factors having a role to play was brought into question by 
the finding by Drapanas ( 65) that cultures taken from ischaernic dog livers were 
sterile. This did not however exclude the possibility that the products of bacteria 
were responsible for the observed effect. 
three hepatic ischaemia review 54. 
In summary, no conclusive evidence was forthcoming which directly implicated 
acidosis, hyperkalaemia or bacterial overgrowth in the postischaemic hypotensive 
response. 
The evidence in favour of VDM or an as-yet-unknown humeral factor was 
strengthened by the finding that hypotension could be avoided if the initial hepatic 
venous effluent following reperfusion was run to waste (37). Moreover, shock could 
be induced in other dogs with inflow stasis by the infusion of the wasted blood. 
Further suggestion that the aetiology of the hypotension involved some other factor 
was provided by the finding that pigs tolerated occlusion of the IVC better than 
occlusion of the portal vein (8). This was suggestive of a contribution by a 
component of portal venous blood, perhaps acting in concert with the ischaemic 
liver. 
The question of whether the hypotension resulted from warm ischaemia per se or 
whether it resulted from the reperfusion of the liver with pooled portal blood was 
indirectly addressed by Nitta (211). Hepatic inflow stasis was induced in two groups 
of dogs, with splanchnic decompression by portocaval shunt provided in the first but 
not the second group. No significant depression in blood pressure was noted in the 
first group but in the group without splanchnic decompression marked hypotension 
occurred and portal venous pressures approached normal systemic levels. 
Importantly, systemic levels of endotoxin were elevated in the non-shunted group at 
the time of portal venous occlusion. 
Clearly the haemodynamic tolerance to hepatic inflow occlusion parallels the quality 
of splanchnic decompression. This has been shown in pigs exposed to 2 hours of 
normothermic ischaemia (214). Furthermore, a correlation between splanchnic 
stasis, endotoxaemia and hypotension appears to exist (215,222). 
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More recent studies have demonstrated the release of potent vasodepressor 
cytokines by macrophages following their activation by endotoxin (228). 
3.5 ISCHAEMIA-REPERFUSION INJURY. 
Reversible ischaemia of the liver is a double insult: damage is incurred both during 
the ischaemic period and during the subsequent period of reperfusion. During the 
past decade, much attention has been devoted to the study of the latter 
phenomenon. Oxygen free radicals have been proposed as mediators of the 
microcirculatory and parenchymal cell injury associated with reperfusion injury 
(1,185,221). 
Much study has been devoted to the identification of the source of these free oxygen 
radicals. Granger, Rutili and McCord proposed that the enzyme xanthine oxidase 
was a major source of the oxidants produced following reperfusion of the feline 
small intestine (104). Their hypothesis was that the enzyme xanthine dehydrogenase 
(XDH) was converted to xanthine oxidase (XO) in ischaemic tissue. Simultaneous 
with this conversion, cellular ATP was catabolized to hypoxanthine during the 
ischaemic period. Upon reperfusion and reoxygenation, molecular oxygen would 
react with hypoxanthine and xanthine oxidase to form the toxic oxygen metabolites, 
superoxide (Qi-), hydrogen peroxide (H2Qi) and the hydroxyl radical (.OH). This 
theory has been adapted from the feline intestine in which it was first described to 
explain the reperfusion injury in various tissues including the liver. 
Much of the evidence implicating oxidative stress in reperfusion injury has come 
from the finding that antioxidants protect against the phenomenon (180). 
Administration of the antioxidants superoxide dismutase (SOD) or catalase 
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attenuate the release of enzymatic markers of hepatocellular injury (1) and improve 
the function of liver grafts exposed to ischaemia (3 ). 
Treatment with alpha-tocopherol (182) and coenzyme Q10; (180) has been shown to 
improve survival, to accelerate the resynthesis of ATP, to lower the consumption of 
both water-soluble and lipid-soluble antioxidants, and to inhibit the lipid 
peroxidation associated with reperfusion injury. 
Glutathione is a major endogenous antioxidant in liver tissue. The concentration of 
reduced glutathione ( GSH) decreases following the onset of ischaemia, whilst the 
concentration of glutathione disulphide (GSSH) correspondingly increases (182). 
The ratio of GSSH to GSH therefore increases following ischaemia, so reflecting 
the prevailing oxidative stress. Exogenous administration of GSH results in the 
decreased formation of lipid peroxides during hepatic reperfusion (181). 
Hepatic ischaemia is associated with decreased adenine nucleotides ( 182), 
decreased superoxide dismutase activity ( 1 ), and depletion of water and lipid-
soluble antioxidants (182). A reduction in endogenous antioxidants would render 
the hepatocytes more susceptible to free radical actions and resultant lipid 
peroxidation. 
There is therefore a growing body of evidence that oxygen free radicals mediate a 
portion of the structural and functional damage associated with reperfusion of 
ischaemic tissues. 
The origin of the oxygen radicals includes activated leukocytes, soluble enzymes and 
proteins, and membrane-bound enzymes of the electron transport chain (95). Of 
these, there has been suggestion that xanthine oxidase is the major source (1). 
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Allopurinol is a competitive inhibitor of xanthine oxidase. The implication of 
xanthine oxidase as a major source of reactive oxygen species is based on the 
observation that allopurinol is as effective as oxygen radical scavengers in 
attenuating the injury associated with hepatic ischaemia (221). This has not however 
been a universal finding. Metzger et al (191) were unable to demonstrate a 
beneficial effect of allopurinol following oxidant stress induced by reperfusion of the 
ischaemic rat liver. A number of unexpected actions has been attributed to 
allopurinol, including the induction of enzymes responsible for the synthesis of free 
radical scavengers and direct scavenging of free radicals. A metabolite, oxypurinol 
has also been implicated in the latter action. Peterson (223) provided evidence that 
allopurinol acts as an electron transfer agent and in so doing facilitates electron 
transport during reperfusion. Metzger, using the standard allopurinol administration 
regimen found no evidence that allopurinol was protective against reperfusion injury 
in the rat liver (191). At much higher concentrations, allopurinol has been shown to 
have a protective effect ( 178). It appears likely that the protective effect of 
allopurinol in high doses is related to direct scavenging of free radicals rather than 
inhibition of xanthine oxidase. 
Given the current uncertainty regarding the specificity of allopurinol action, it 
appears that an alternate means of studying xanthine oxidase inhibition should be 
sought. Possible modalities include folate, methotrexate and a tungsten-
supplemented, molybdenum-deficient diet (221). 
The duration of ischaemia is vital since it has been shown that significant xanthine 
dehydrogenase to xanthine oxidase conversion occurs only after 2 hours of 
ischaemia (75). Therefore if xanthine oxidase conversion had a significant part to 
play in the genesis of reperfusion injury, it would only occur where the ischaemic 
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period was of sufficient duration. Any benefit attributable to xanthine oxidase 
inhibition would then be unlikely in ischaernia of shorter duration. An 
understanding of the kinetics of the xanthine dehydrogenase to xanthine oxidase 
conversion is important therefore in the interpretation of studies of free radical 
production (221). 
Finally, there are a several other possible sources of oxygen free radicals other than 
xanthine oxidase. Recent work by Grisham et al (107) suggests that neutrophils are 
the source of free radicals and the ultimate mediators of reperfusion injury. In their 
view, xanthine oxidase-derived oxidants appear to play a more important role as 
initiators of neutrophil infiltration rather than mediating rnicrovascular injury ( 107). 
The role of neutrophils in reperfusion injury of the liver remains undefined. The 
finding that reperfusion injury in the liver is an oxidative stress that is not modified 
by allopurinol (191) clearly outlines the need for further work in this field. 
3.6 PARAMETERS OF HEPATOCELLULAR INJURY. 
Another difficulty in the interpretation of results is created by the use of different 
indices of liver damage in different studies. The commonly used indices generally 
fall into 4 groups: 
a) those relating to changes in cellular permeability or cytolysis, 
b) altered hepatocyte function, 
c) impaired circulatory function, 
d) resulting from oxidative stress (221). 
three hepatic ischaemia review 59. 
Release of endogenous aspartate aminotransferase (AST), alanine aminotransferase 
(ALT) and lactate dehydrogenase (LDH) are the commonest indicators of cellular 
injury (93). There is evidence however to suggest that the release of cytosolic 
enzymes may not be adequate indicators of early cellular damage (56). The 
phenomenon of potocytosis, by which apical blebs are lost from ischaemic, but not 
necrotic cells contributes to the elevation of transaminase levels following ischaemia 
(102). The presence of blebs on hepatocytes has been reported following storage of 
rat liver allografts (40,189). The mitochondrial enzymes ornithine carbamyl 
transferase (94) and mitochondrial AST (210) have been utilized as indices of 
hepatocellular necrosis in an attempt to circumvent this problem. 
Apart from estimations of mitochondrial integrity, many different techniques have 
been utilized to assess the impairment in hepatic function associated with ischaemia 
and reperfusion. These include oxygen consumption, bile flow, bile acid production, 
dye recovery, ATP clearance, protein and DNA synthesis (221). In a study in 
isolated perfused rat livers, bile flow ceased after 15 minutes of warm ischaemia 
( 19). In the transplantation setting this may be of great clinical usefulness. 
Few investigators have attempted to quantitate the degree of oxidative stress 
following ischaemia/reperfusion. Lipid peroxidation is a complex process whereby 
unsaturated lipid material undergoes reaction with molecular oxygen to yield lipid 
hydroperoxides. Methods that have been utilized to quantitate this include 
measurement of the loss of unsaturated fatty acids and phospholipids and 
production of alkanes, chemiluminescence, diene conjugation, thiobarbituric acid-
reacting substances and protein carbonyls (221). 
Clearly no consensus has been reached as to which index of hepatocellular injury is 
most appropriate. 
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3.8 THE HEAT SHOCK RESPONSE. 
When a cell is exposed to stressful situations, such as increased temperature or 
ischaemia, it abruptly begins to synthesize large quantities of several specific 
proteins to the relative exclusion of others (99). These are termed heat-shock 
proteins and the response is the heat-shock response. This phenomenon was first 
described in Drosophila by Ritossa (246), but subsequent studies have demonstrated 
heat-shock proteins in a number of species including man. Heat-shock proteins are 
identified by their molecular weights, being referred to for example as hsp84, hsp70 
or hsp22. Thus hsp70 has a molecular weight of 70kD. In the original description in 
Drosophila puffing of the DNA in specific chromosomal regions was noted and these 
regions accounted for the sites of heat-shock protein synthesis (246). Approximately 
30% of protein synthesis occurring after heat shock was accounted for by 6 of these 
proteins (294). It has been postulated (159) from bacterial models that in response 
to oxidative stress, adenylated nucleotides (alarmones) are synthesized which serve 
to trigger the synthesis of heat-shock proteins ( 159). One of these nucleotides is 
adenosine tetraphosphate (ApppA). 
Wann ischaemia and the heat-shock response. 
Most metabolic activities, including protein synthesis are impaired shortly after the 
onset of ischaemia (39). Protein synthesis decays progressively with time, and 
returns to normal only if ischaemia does not exceed 60 minutes (39). It would 
appear unlikely that proteins of any description are synthesized during the period of 
ischaemia. Synthesis of heat shock proteins has been demonstrated in the period 
following warm ischaemia in the rat liver (38). Postischaemic recovery of rat liver 
results in the accumulation of polysomes with resultant increased expression of 
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genes coding for the hsp89 and hsp70 heat-shock proteins (99). This is facilitated by 
the structural features of heat-shock protein mRNA that confer on them a high 
intrinsic translational efficiency (38). 
Like acute phase proteins, heat-shock proteins are produced in response to a variety 
of noxious stimuli. This suggests that they may have some protective effect. The 
phenomenon of thermotolerance, in which animals demonstrate enhanced heat 
tolerance on second exposure supports this hypothesis. According to the adenylated 
nucleotide alarmone theory, alarmones would induce the heat-shock response as 
protection against oxidative stress (159). 
The association between the heat-shock response and the acute phase reactants 
such as C-reactive protein is suggestive that they may constitute part of the same 
universal response to stress (294 ). Differential molecular weights, and the finding 
that acute phase proteins are synthesized at a later time during the postischaemic 
recovery, provide conclusive evidence of two distinct phenomenae ( 6). 
Liver regeneration and the heat-shock response. 
Carr ( 46) studied the expression of heat-shock proteins following the administration 
of hepatocarcinogens and during hepatic regeneration. Increased levels of both 
hsp83 and hsp70 were demonstrated following administration of hepatocarcinogens 
and during hepatic regeneration. This suggested their expression during both normal 
and abnormal hepatocyte proliferation. These results are similar to those observed 
for expression of c-H-ras amd c-myc in rat liver during regeneration (175), and 
suggest a coordinate expression for these genes during liver regeneration. 
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The alteration of rat hepatocytes, with the resultant heat shock response that occurs 
following the administration of hepatocarcinogens or during liver regeneration is 
capable of protecting against the cytocidal effects of toxins such as adriamycin ( 4 7). 
The c-H-ras and the c-myc oncogenes, like the heat-shock proteins, are elevated 
following administration of hepatocarcinogens and during liver regeneration ( 46). 
The biologic significance of the increased expression of these genes during both 
normal and abnormal growth is not clear. Resistance of hepatocytes to toxins occurs 
likewise during both normal and abnormal growth. It is possible therefore that the 
heat-shock proteins participate in an alteration in hepatocyte function that mediates 
a resistance to a variety of toxins. Lee et al (159) postulated that all agents capable 
of causing oxidative stress induce the heat-shock response. The products of this 
response would then mediate protection against subsequent oxidative attack. 
In summary, the biological significance of the heat-shock phenomenon remains 
obscure. The expression of these proteins during both normal liver regeneration and 
following ischaemic injury to the liver suggest they may be of importance in the 
interpretation of this study. 
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4. PARTIAL ORTHOTOPIC LIVER TRANSPLANTATION. 
Orthotopic liver transplantation has become the standard treatment for adults and 
children with irreversible liver disease (84,276). The earliest efforts in liver 
transplantation were limited by the concept that removal of the liver was a 
prohibitive surgical undertaking, and that the animal was unlikely to survive the 
anhepatic phase. Recent refinements in surgical technique, including novel 
haemostatic modalities and advances in liver preservation (139) have greatly 
facilitated the procedure, to the extent that the single greatest limitation to the use 
of liver transplantation in clinical practise is the availability of donor organs. 
Partial orthotopic liver transplantation (POLT), in which the donor liver is surgically 
reduced by ex vivo hepatic resection, was first developed to overcome the problem 
of space experienced in models of auxiliary liver transplantation (84). This 
technique found its first clinical usage in 1984 when Bismuth reported the 
transplantation of a reduced-size liver graft (14). The technique has been 
increasingly used to overcome the size disparity between donor and recipient in 
paediatric liver transplantation. The obvious wastage of hepatic parenchyma 
associated with this procedure has prompted further innovation, in the form of the 
split liver graft. In this procedure the liver is divided into two, so providing donor 
material for two patients. 
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4.1 THE NEED FOR NOVEL TRANSPLANTATION TECHNIQUES. 
A dramatic improvement in the results of orthotopic liver transplantation (OLT) 
has been reported over the last decade (276). With an overall 4 year survival rate of 
81 % (23), liver transplantation is having an impact on mortality in paediatric liver 
disease. In contrast, the mortality of children with biliary atresia is over 50% without 
transplantation (169). Moreover, the success rate for the Kasai procedure for biliary 
atresia is in the order of 30% (169). 
Pretransplant mortality is a major problem in paediatric liver transplantation, 
particularly in the under 2 age group where scarcity of donors is even greater. Lilly 
and Hall (169) reported that pretransplant mortality of their patients with biliary 
atresia exceeded transplant mortality, with most deaths occurring in infants. In 
Pittsburgh, one quarter of children accepted as candidates for transplantation died 
prior to a liver becoming available ( 176). 
Part of the explanation for this is the delayed referral of potential transplant 
recipients, due to decreased awareness of the benefits of transplantation. 
Furthermore, there appears to be a "marked disparity between the optimism of the 
transplant centres and the pessimism of the referring paediatricians" (71). 
Paediatric liver disease primarily affects infants and small children. In the USA 55% 
of paediatric deaths due to liver disease occur in the age group O to 2 years ( 69). In 
contrast, children under 1 year of age made up only 10% of a large reported series 
of paediatric liver transplants. Technical difficulty is usually cited as the major 
reason for OLT not being performed in infants. 
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The shortage of paediatric liver donors was analyzed by Emond et al (69). Only 4% 
of livers were of suitable size for infant recipients. In addition, only 32% of adult 
and school-aged renal donors yielded a liver for donation (69). Therefore, not only 
was there an absolute shortage of small livers, but the available livers from older 
donors were under-utilized. A more recent study demonstrated an improved yield, 
with livers being harvested from 71 % of renal donors (70). 
Although it could be argued that using larger donors for small recipients places 
larger recipients at risk for not receiving a transplant, the patterns of organ 
donation suggest that older children still benefit from the more abundant supply of 
grafts in their age group. 
The usage of RLT to improve liver utilization by overcoming size disparity has had a 
positive effect on waiting-list mortality in many centres since its inception (69,217). 
Simple graft reduction does not increase the total number of available livers. The 
technology of RLT has therefore been extended to include split liver 
transplantation, in which a liver is divided to create two grafts, and live donor 
hepatic transplantation. 
4.2 SURGICAL ASPECTS. 
The external morphology of the liver does not reflect its internal 'functional' 
architecture. The segmental anatomy of the liver is based on the branches of the 
portal vein as described by Bismuth (13,14). This knowledge has provided the 
anatomical basis for the advances in surgery of hepatic resection and reduced liver 
transplantation. Preparation of a reduced graft is accomplished by ex vivo 
hepatectomy based on the anatomic planes between functionally independent 
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portions of the liver. In practice, three separate grafts can be prepared for 
overcoming various degrees of size disparity (21). The right lobe is used when the 
size disparity between donor and recipient does not exceed 2: 1, whilst usage of the 
left lobe is possible with a size disparity of up to 4: 1 (21 ). A graft composed of 
segments 2 and 3 can be used to make up a disparity of up to 10: 1. The donor vena 
cava is used for full right and left grafts, whilst the left hepatic vein is used for left 
lateral lobe grafts. Roux-en-Y hepaticojejunostomy is used for biliary reconstruction 
of all types of reduced liver grafts (71). 
4.3 NOVEL TRANSPLANTATION TECHNIQUES. 
Response to the increasing pressure of donor shortages has resulted in the advent of 
novel transplantation modalities. These have endeavoured to extend the utilization 
of donor material in different ways, and include reduced-size liver transplantation 
(RL T), split liver transplantation (SLT) and liver transplantation using a living 
donor (LRT). 
4.3.1 Reduced-size liver transplantation (RLT). 
This procedure was first performed by Bismuth and Houssin (14). The initial 
experience of Broelsch et al (22) with RL T was in a group of patients who were 
critically ill and not expected to survive the time to perform a conventional organ 
search. Although the survival was poor, the experience obtained demonstrated that 
the procedure was feasible. 
An added advantage was that RLT reduced the mortality of patients on the 
transplantation waiting list, by improving donor organ utilization. A reduction of 
pre-transplant mortality to 7% was reported by Broelsch et al as a consequence of 
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the initiation of a RL T program (22). This compared favourably to centres in which 
intact OL T only is performed, where between 25 to 50% of potential paediatric 
recipients do not survive to transplant (22). Ethical studies demonstrated that even 
with the increased mortality associated with RLT, a reduction in global mortality 
was accomplished (267). With increasing experience, technical complications 
diminished and survival improved. In addition, the advent of UW solution ( 139) 
made extended preservation of the liver possible and has permitted extensive ex vivo 
surgery on the transplanted liver to become routine. A recent report from Chicago 
gives the survival of paediatric recipients of RLT at 78% against 81 % for full-size 
grafts (71). The corresponding data from Brussels indicate a 77% survival rate for 
RLT against 85% for full-size OLT (218). These rates were not statistically 
significantly different. 
The complication rates for the two procedures were similar. Of interest was that 
primary non-function was less common in RL T (70). This may reflect less stringent 
donor selection being employed for paediatric size-matched organs, which again 
reflects the paucity of donor livers in the paediatric age group. Furthermore, arterial 
thrombosis was more common in OLT than in RLT (70). This may reflect the larger 
calibre of vessels in the larger donors. Biliary complications were not more common 
after RLT (71). 
A further most useful application of the technique may be for retransplantation, due 
to the emergent nature of this indication and the greater availability of reducible 
adult donor material (70). 
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4.3.2 Split liver transplantation (SLT). 
Simple reduction of the liver graft, while improving the utilization of available 
donors, does not expand the available pool of donor livers. The practice of split liver 
grafting is based on the success of an initial operation performed by Pichlmayr 
(225), who had previously introduced the concept of ex situ liver resection and re-
implantation (224 ). 
Susequently, Emond et al (70) have reported a series of 30 patients in which two 
grafts are prepared from a single donor. In contrast to simple graft reduction, this 
adds significant complexity to the transplantation procedure. Over and above 
increased technical demands, it requires the performance of two concurrent 
recipient procedures, utilizing two surgical teams. 
Although children receiving RLT have done as well as those receiving OLT, this has 
not been shown in adults. Implantation of a SLT into an adult would require 
knowledge that firstly, the regenerative capacity of the transplant is intact and 
secondly, that the graft is capable of normal liver function. These uncertainties have 
resulted in ethical questions being raised as regards the usage of SLT in adults. 
Innovative approaches in children have been supported in concept due to the lack of 
paediatric donors. The same support for innovative surgery may be lacking in adults 
where the shortages are not as acute. Nevertheless, improved results in paediatric 
recipients of SL T may bring increasing acceptance of SL T as a treatment modality 
in adults with end-stage liver disease. 
There is little in the reported literature on the usage of this technique (SLT). 
Broelsch et al report an overall survival rate of 67% and graft survival of 55% in a 
series of 21 children (23). Complications were however more frequent in SLT than 
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in full size OLT. Haemoperitoneum occurred in 33% of SLT against 14% in full size 
grafts. Biliary leakage complicated 27% of SLT against 4% in full size OL T. Arterial 
thrombosis and primary non-function occurred with equal frequency in both groups 
(70). 
The results of SLT in adult patients are less encouraging, with a reported graft and 
patient survival of 25 % in a group of 4 adults receiving SLT (23 ). However, all of 
the adult recipients received their transplants exclusively in emergency 
circumstances. Biliary complications occurred in more than a quarter of patients. 
Arterial thrombosis was no more common in SL T than in other grafts, even though 
many SLT utilize interposition grafts. Necrosis of segment 4 was reported in 2 cases. 
Bismuth et al ( 15) have however reported on two cases in which SL Twas performed 
on two adult recipients in emergency circumstances. Both died from causes not 
specifically related to operative technique, one from multiple organ failure on the 
20th day and the other from systemic cytomegalovirus infection on the 45th day. 
In the opinion of Emond et al (71), optimal use of SLT is currently restricted to the 
treatment of 2 children with a single paediatric donor. 
4.3.3 Liver transplantation using a living related donor (LRT). 
Statistics obtained from kidney transplantation centres have shown that tissue 
compatibility with the recipient is the most important factor deciding the fate of a 
transplanted organ. Kidneys from living related donors have the best graft survival, 
whilst those obtained from unmatched cadavers have the worst survival statistics. 
These observations led to the proposal of living related liver transplantation by 
Smith in 1969 (269). Only recently, due to the advances in liver transplantation 
technology has it been considered technically feasible. 
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An absolute imperative for the clinical usage of this technique is negligible donor 
mortality. A further prerequisite is acceptable survival rates for graft and recipient. 
The technique of hepatic inflow occlusion has reduced the complications of liver 
resection to a point where mortality for the procedure is negligible and the need for 
blood transfusions diminished (292). Usage of this technique should likewise 
diminish morbidity in the LRT donor. 
The procedure has been tested in a laboratory animal model (53). The results of the 
latter study in dogs suggested that a viable graft could be obtained, and that the 
donor procedure was safe (53). However, it was not possible to achieve prolonged 
survival in the recipients. 
The first LRT was performed in two patients in Brazil by Raia in 1989 (241). 
Unfortunately both recipients died despite technically successful transplants. 
Subsequently, Strong has successfully performed a RL T for a patient with biliary 
atresia, with good results for both donor and recipient at 6 months follow-up (282). 
The preliminary results of Broelsch et al have been reported in a series of 5 cases 
(23). In this series, complications were not experienced in those donors in which a 
left lateral segment only was transplanted (23). In those in which total left 
hepatectomy is performed, all three developed complications. These included bile 
leakage from the transected parenchyma, a subhepatic fluid collection and an 
intraoperative splenic tear requiring splenectomy. It appears that donor morbidity is 
significant where total left hepatectomy is performed (23). This would suggest left 
lateral hepatectomy as the routine donor operation, although this adds significantly 
to the technical difficulty of the recipient procedure. This was performed in the 
latter 2 cases in this series. This procedure obviates the need to dissect and discard 
segment 4, as in the case of the total left hepatectomy (23). 
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In the same five patients reported from Chicago, patient and graft survival is 
reported as 100% for donors and recipients with follow-up from 2 to 6 months (23). 
These results, although very encouraging, should probably not be judged until 
several years of accumulated experience are available. 
The main benefit of RLT is a reduced risk of pretransplantation mortality. At most 
liver transplant centres, because of the shortage of donors, up to 50% of potential 
recipients die awaiting transplantation (69,169,176). Additional benefits include a 
totally elective transplant procedure, potentially improved graft quality since it is 
harvested from a live donor, and the possible immunologic advantage conferred by a 
related donor. 
The ethical considerations of RLT require a careful decision-making process in 
order to assess correctly the relative risks to both donor and recipient. Donor 
selection is critical and requires an elaborate procedure for the assurance of 
informed consent. 
In conclusion, the techniques of reduced, split and living donor liver transplantation 
are making it possible to treat all children needing liver transplantation despite the 
limitations in supply of cadaveric donors. Liver transplantation has already had a 
clear impact on global mortality in children with liver disease (276). As therapy for 
the future, orthotopic liver transplantation may not be exclusively based on cadaver 
organ donation. 
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4.4 LIVER REGENERATION AFTER INTACT AL~D REDUCED 
TRANSPLANTATION. 
The inherent capability of the liver to regenerate is well known. Hepatocyte 
proliferation following transplantation is less well documented. An attenuated 
pattern of hepatocyte proliferation has been demonstrated in pigs ( 134) and rats 
(73,290) following intact liver transplantation. This diminished response may 
however reflect the absence of a true regenerative stimulus, since the mass of liver 
transplanted in these studies was similar in size to the native liver, and therefore 
represented a similar liver-body mass ratio. A similarly diminished regenerative 
response, albeit measured only by increase in volume of the transplanted liver, has 
been shown in dogs by Kam et al (142). Where the transplanted liver was of a 
similar size to the donor liver, a negligible increase occurred, whereas an increase in 
graft volume was noted where the transplanted liver was small-for-size. This study 
introduced the concept that recipient size determines, at least in part, liver graft size 
after transplantation. 
Enlargement of small-for-size intact liver grafts has been reported in two transplant 
patients by Van Thiel et al (295). Despite graft enlargement, no evidence of an 
increased rate of DNA synthesis or hepatocyte proliferation was shown. 
Furthermore, the absence of a relationship between liver enlargement and serum 
levels of putative hepatotrophic substances in this study served to illustrate a clear 
need for a specific marker of hepatocyte proliferation following clinical 
transplantation. 
The regenerative response has been studied following partial orthotopic liver 
transplantation in dogs (9) and in pigs (248). In the former study, the liver weights 
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were studied at 24 weeks postoperatively and found to be similar in mass to the 
native liver. In the latter study, the liver weight at the time of sacrifice was noted to 
be greater than at the time of operation. In neither of these studies was the question 
of hepatocyte proliferation or DNA synthesis specifically addressed however, nor 
was the time course of liver regeneration following transplantation studied. 
The regenerative capacity of the liver is often been assumed to be constant, whether 
it be following reduced-size transplantion or hepatic resection (53). This may not be 
the case. 
Given the discrepancy between the numbers of organs transplanted and the number 
of patients requiring transplantation, there is an ever increasing need for these 
innovative transplantation modalities. Concomitant to the successfull usage of small-
for-size liver transplantation is knowledge of the proliferative kinetics of the 
transplanted hepatic parenchyma. In addition, there is a need for the development 
of noninvasive and direct measurements of hepatocyte DNA synthesis and mitosis in 
the transplanted liver. A further question is whether regeneration is indeed 
desirable in view of the attenuation of critical liver function known to occur at this 
time (154). 
The current study of hepatocyte proliferation attempts to answer some of these 
questions. 
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5. STATEMENT OF OBJECTIVE. 
Having reviewed the literature pertaining to liver regeneration, the effects of 
hepatic ischaemia, and partial orthotopic liver transplantation, it is apparent that 
the regenerative response following partial liver transplantation has not been fully 
documented. There has been enormous recent progress in the development of new 
transplantation modalities, one of which may utilize reduced donor livers for adult 
recipients. This procedure has numerous potential complications, only one of which 
may relate to the often assumed capacity of the transplanted liver segment to 
regenerate. Although it is likely that this will occur, the magnitude and time course 
of this proliferative response is unknown. The overall purpose of this study therefore 
is to examine hepatocyte proliferation and DNA synthesis after partial orthotopic 
liver transplantation in the rat model. 
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6. GENERAL METHODS. 
Materials and methods used in all experiments will be discussed in this chapter, 
whilst procedures unique to the particular experiment will be discussed in the 
relevant section. 
6.1 Animals. 
Male Long-Evans rats weighing 250-350 grams were used in the study. The animals 
were maintained on standard rat feed ad libitum until 24 hours prior to surgery. 
They were allowed free access to water throughout. Animals were kept in cages at 
0 
22 C with fixed daylight cycling, with cages lit between 07:00 and 19:00. They had 
been trained in the feeding and lighting schedule from birth. 
6.2 Anaesthesia. 
All surgical procedures were performed under ether anaesthesia. A bell jar was used 
for induction, and a nose cone for the delivery of maintenance anaesthesia. 
Preference was given to an inhalational agent, due to the need to rapidly alter the 
level of anaesthesia in some of the experiments. 
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6.3 Surgery. 
Clean, but not sterile technique was used throughout. Microsurgical technique was 
employed where necessary. All procedures were performed between 09:00 and 
12:00 in order to avoid variations in hepatic regeneration due to circadian rhythm 
(32). Times of sacrifice were adjusted accordingly. A midline laparotomy extending 
from the xiphisternum posteriorly for + - 6 cm was performed in all cases. 
Details of specific procedures are mentioned in the relevant chapters. In all cases 
the laparotomy wound was closed in two layers by continuous suture using 3 /0 
chromic catgut. Following all procedures, animals were allowed to recuperate in a 
warmed environment until fully awake after anaesthesia. They were then returned 
to their holding cages and allowed free access to water and feed. Non-survivors were 
examined at autopsy whenever this was feasible, and the cause of death noted. 
The programme was accepted by the Animal Ethics Committee, University of Cape 
Town. 
6.4 Sampling. 
Groups of rats (n=4-9 per group according to survival) were exsanguinated by aortic 
puncture under ether anaesthesia after periods of 4, 24, 48, 72 and 96 hours. A 5 ml 
blood sample was taken for measurement of aspartate aminotransferase. The liver 
was removed and the mass determined. The liver was divided into four: two sections 
of at least 1 gram for thymidine kinase and ornithine decarboxylase assay, a section 
for histological examination and a section for the determination of tissue water. The 
0 
latter section was weighed before and after being dried in an oven at 70 for 48 hrs 
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in order to determine tissue water. Sections of liver for thymidine kinase and 
ornithine decarboxylase assay were immediately placed in liquid nitrogen for 
storage. 
6.5 Parameters of liver regeneration. 
The following parameters were used as indicators of regenerative activity: 
6.5.1 Restitution of liver weight. 
The mass of the remnant liver was determined at the time of sacrifice. A section of 
this liver was weighed, then dried in an oven for 48 hrs, and weighed again in order 
to determine tissue water. The gross mass of the liver was corrected for differences 
in tissue water and expressed as an index (liver mass index or LMI) of the animal's 
mass at the time of sacrifice. 
Tissue water was calculated by the formula: 
tissue water = ( Mw - Md ) 100 / Mw. 
Liver mass index was calculated by the formula: 
LMI = ( M1 x Md / Mw ) / ( Max 1a2 ). 
Where LMI = liver mass index 
M1 = mass of liver remnant 
Mw = mass of fresh liver sample 
Md = mass of dried liver sample 
Ma = gross mass of animal at sacrifice. 
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6.5.2 Thymidine kinase activity. 
Thymidine kinase activity was assayed in the (1 gram) sample of liver tissue by 
standard methods (133). Briefly, weighed portions of frozen pulverized liver were 
homogenized in 10 vol of buffer (0.1 M Tris-HCl, pH 8.0) using a Ultra-Turrax 
0 
homogenizer. The homogenate was centrifuged at 105 000 gav. for 60 min at 4 C in 
a Beckman Ll.65 ultracentrifuge. The supernatant, which was carefully aspirated 
avoiding the top layer containing fat, served as an enzyme source. 
Samples for background activity were prepared by terminating the reaction as soon 
as all components were mixed together, and these zero time values were then 
subtracted from the values obtained at the end of the incubation period. In each 
assay a standard sample containing a known amount of radioactive substrate was 
prepared. 
The reaction mixture contained in a final volume of 1.0 ml: 0.05 M Tris-HCl buffer 
(pH 8.0), 5 mM ATP, 3.6 mM MgClz, 0.01 mM [3H]thymidine, and 0.2 ml of 
0 
supernatant. The reaction mixture was incubated for 10 min at 37 C, and the 
reaction was stopped by immersing the assay tubes in boiling water for 2 minutes. 
The tubes were cooled on ice, and the denatured protein was removed by 
centrifuging at 100 g for 10 min. Duplicate aliquots of 0.1 ml each were removed 
from each assay tube and spotted onto DEAE-cellulose discs. The discs were 
washed in 1 mM ammonium formate (25 ml) for 5 min, distilled water (25 ml) for 3 
min, ammonium formate for 5 min, and finally rinsed in distilled water again. The 
discs were allowed to drain and were then placed in scintillation vials. To each vial 
was added 1.0 ml of 0.1 M HCl/0.2 M KCl solution. The vials were gently shaken 
for 15 min to allow the labelled nucleotides to be eluted from the exchange paper. 
After elution was complete, 10 ml of "Instagel" (Packard Instrument Co., Downers 
Grove, Ill.) was added to each vial, and the vials were shaken until the emulsion was 
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clarified and the discs were fully permeated with solvents. The discs were counted 
for radioactivity in a Beckman 3-channel scintillation counter. 
Results were expressed as disintegrations per minute per milligram protein ( dis.min-
1.mg protein -1 ). 
6.5.3 Omithine decarboxylase activity. 
Ornithine decarboxylase activity was assayed in the (1 gram) sample of liver tissue 
by standard methods (186). Briefly, the enzyme was assayed in vitro by measuring 
the release of 14C02 from 0L-[l-14C]ornithine (SOmCi/mmol; Amersham, 
England). Excised livers were homogenized in 0.25 M-sucrose containing 0.5mM 
EDTA, lOmM-mercaptoethanol and lOmM-Tris/HCl buffer, pH 7.4. The 
homogenates were centrifuged for 60 min at 36 000 gav. in a Beckman LS.65 
ultracentrifuge and samples of the cytosol were assayed for enzyme activity. The 
incubation mixture (1ml total) consisted of 0.4 ml of cytosol, 0.2 mol of pyridoxyl 
phosphate, 5mM-dithioreitol, lOmM-Tris/HCl buffer, pH 8.0, and 0.8 Ci of [l-
14C]ornithine and unlabelled L-ornithine to 2mM. After pre-incubation for 5 min at 
0 
37 C, labelled ornithine was added and the tubes were capped and incubated for 60 
min. The 14C evolved during the reaction was trapped in KOH spotted onto the 
filter paper. For radioactivity determination the filter paper was placed into a vial 
containing scintillation fluid. 
6.5.4 Histology. 
A segment of the liver was stored in formol saline at the time of sacrifice. Sections 
of liver tissue were prepared by paraffin section and stained with haematoxylin and 
eosin. Sections were examined for fatty infiltration and evidence of hepatocyte 
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proliferation. Mitotic figures were counted and expressed as mitoses per 1000 cells 
(mitotic index). 
6.6 Aspartate aminotransferase (AST). 
Blood samples for AST were collected into heparinised tubes. The 5 ml blood 
sample was centrifuged at 30000 rpm for 10 minutes. Plasma was decanted and 
frozen for subsequent AST assay by standard methods. 
6. 7 Data analysis. 
Data were expressed as the means + - standard error. Data were compared using 
one-way ANOVA at each point, and two-way ANOVA where appropriate. The level 
of significance was at least p < 0.05 for all experiments. 
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7. PARTIAL HEPATECTOMY. 
This component of the study aimed to establish a universal control against which 
other experimental groups could be compared. Although the regenerative response 
to partial hepatectomy has been previously documented in this laboratory (133), it 
remained nevertheless important to establish a standard pattern of hepatocyte 
proliferation under constant conditions to be applied in each experiment. 
7.1 Methods. 
7.1.1 Sham operation. 
Sham operation comprised a midline laparotomy and liver dissection to free all 
attachments and collateral blood vessels. These animals were immediately sacrificed 
under anaesthesia. Sampling was performed as previously described. 
7.1. 2 Partial hepatectomy. 
Laparotomy was performed as for sham animals. Full hepatic dissection as 
described for subsequent groups was not performed (see Chapters 8-12). 
Standardized 68% partial hepatectomy was employed as described by Higgins and 
Anderson ( 116). This was modified by the application of a vascular clamp to the 
porta hepatis prior to partial hepatectomy, in order to secure inflow occlusion and 
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minimize blood loss. The liver was then extruded through the abdominal incision 
and the median and left lateral lobes ligated at their base using a 5 /0 silk tie, and 
resected. Care was taken in the placement of the suture so as not to include the 
vena cava. The clamp was then removed. This manouevre markedly minimized 
blood loss at the time of partial hepatectomy. The duration of hepatic ischaemia 
associated with this procedure was less than 60 seconds. Animals were sacrificed 
after periods of 4, 24, 48, 72 and 96 hours, and sampling performed as described. 
Sampling could potentially have been performed at intervals of 2 to 4 hours to 
define each peak of activity as closely as possible. However since this may not have 
provided greater clarity on the definition of the peak, and considering the 
implications in terms of animal usage, this was not considered justifiable. The term 




Of the 52 rats in this group 50 survived until the time of sacrifice (96.1 % ). There 
was no mortality in sham-operated animals (n=6). 
7.2.2 AST. 
Plasma AST reached a maximum of 390 + -31 at 24 hrs after an initial elevation of 
328+-40 at 4 hrs. Thereafter there was a gradual decline to 192+-32 at 72 hrs and 
111 +-9 at 96 hrs. In shams AST levels were 93 +-5. 
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7.2.3 Tlzymidine kinase. 
Thymidine kinase levels reached a recorded maximum at 24 hrs (36021 + -8060). The 
elevation persisted at 48 hrs (26042 + -3957) and showed a smaller peak at 72 hrs 
(28378+-5545). By 96 hrs levels had declined to 10179+-982 (Table 7.1). The 
activity in sham-operated animals was 8071 + -979 at the time of operation. 
7.2.4 Mitotic index. 
The mitotic index reached a recorded maximum of 25 + -8 at 24 hrs. This 
corresponded to the peak of thymidine kinase activity. Therafter the mitotic activity 
diminished to levels of 9+-3 at 48 hrs, 14+-3 at 72 hrs and 9+-2 at 96 hrs. A second 
wave of mitotic activity was apparent however, with the mitotic index at 72 hrs 
greater than that at 48 hrs (Table 7.1). In sham-operated animals the mitotic index 
was 1+-0.3. 
Table 7.1 Thymidine kinase activity ( dpm per mg protein) and mitotic index 
'mitotic fif!Ures oer 1000 cells 1 after oartial heoatectomv in f astPd rats. 
Time Thymidine kinase Mitotic index 
Shams 8071 +-979 1 +-0.3 
4 hrs 4637+-796 1 +-1 
24 hrs 36021 + -8061 25+-8 
48 hrs 26042 + -3957 9+-3 
72 hrs 28378 +-5545 14+-3 
96 hrs 10179+-983 9+-2 
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7.2.5 Liver mass index and tissue water. 
The liver mass index of sham-operated animals gives an indication of the normal 
liver to body mass ratio in fasted Long-Evans rats. The liver mass index showed a 
progressive increase from 4 hrs through to 72 hrs, and subsequently declined. No 
significant differences were noted in tissue water in the 96 hours following partial 
hepatectomy (Table 7.2). 
Table 7.2 Liver mass index (LMI) and tissue water after partial hepatectomy in 
•asted rats. 
Time Liver mass index Tissue water 
Shams 0.942 + -0.07 68.2%+-0.5% 
4 hrs 0.353 + -0.028 71.6% + -1.4% 
24 hrs 0.517+-0.021 70.2%+-0.3% 
48 hrs 0.755+-0.03 71.2%+-0.5% 
72 hrs 0.835 + -0.043 71.4%+-0.4% 
96 hrs 0.732+-0.053 71.2%+-0.4% 
7.2.6 Omithine decarboxylase. 
Ornithine decarboxylase levels reached a recorded maximum of 313 +-80 at 4 hrs. 
Thereafter ODC activity declined progressively (Table 7.3). ODC activity in sham-
operated animals was 76 +-13. 
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Table 7.3 Omithine decarboxylase activity (cpm per mg protein) after partial 
henatectomv in fm.tPd rats. 
TIME ODC 
Shams 76+-13 
4 hrs 313 +-80 
24 hrs 109+-26 
48 hrs 144+-32 
72 hrs 121+-19 
96 hrs 171+-77 
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Figure 7.1 Liver regeneration following 68% partial hepatectomy. Parameters of liver 
regeneration measured were the liver mass index ( LMI), thymidine kinase ( dpm per mg 
proteinj, mitotic index ( mitotic figures per I 000 cells) and omithine decarboxylase ( ODC) 
( cpm per mg protein). Animals were sacrificed 4, 24, 48, 72 and 96 hrs after partial 
hepatectomy. Results were expressed as means +- SE. 
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7.3 Discussion. 
This group served as a universal control against which other experimental groups 
were compared. The response of the rat liver to partial hepatectomy has been 
studied for over 60 years ( 116). This simple technique is highly reproducible and 
well tolerated, and provides the stimulus for the regenerative response. Not all rats 
respond to partial hepatectomy in an identical fashion, however. The rate of DNA 
synthesis in weanling rats follows a biphasic curve, with peaks at approximately 20 to 
22 hours and 33 to 35 hours after partial hepatectomy. In young adult Holtzman rats 
a single broad peak appears somewhat later, at 23 to 25 hours ( 4 months old, 
averaging 233 +-22 gram) (29). The span of this peak is approximately 12 hours as 
compared to the very narrow peak in weanling rats. Peak mitotic activity follows 
maximal DNA synthetic activity by about 6 to 8 hours (32). It was desirable in the 
present study to utilize rats in which the hepatocellular proliferation kinetics had 
been previously studied and were well-known. Furthermore, from previous work on 
liver transplantation in rats done in this laboratory (72), it has been our experience 
that optimal survival occurs in rats of mass greater than 300 grams. Given these 
restrictions, Long-Evans rats of 3 months age with an approximate weight of 300 
grams were used (range +-50 grams). The broad peak of DNA synthesis previously 
observed in these animals following partial hepatectomy (29) would serve to obviate 
the need to perform closely spaced observations to detect a narrow peak of DNA 
synthesis. The slightly older animals could also be expected to survive the 
transplantation procedure in a more predictable manner. A time of 24 hours after 
partial hepatectomy was chosen therefore as the most likely to show peak DNA 
synthesis in animals in the chosen weight range. 
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Marked changes in polyamine metabolism occur in regenerating rat liver (186). 
Ornithine decarboxylase is the rate-limiting enzyme in polyamine synthesis in 
mammalian tissues. Ornithine decarboxylase activity following partial hepatectomy 
follows a biphasic curve, with maxima occurring at 4 to 6 hours and at 16 hours 
( 186). In order to study polyamine metabolism therefore, a time interval of 4 hours 
after partial hepatectomy was chosen for sampling. 
Times of 4 and 24 hours were therefore chosen to represent the likely maxima of 
ODC and thymidine kinase activity respectively. The remaining time periods, 
namely 48 hours, 72 hours and 96 hours were arbitrarily chosen. 
The peak in thymidine kinase activity in this group was recorded at 24 hours, with 
activity remaining significantly elevated until 72 hours. Kahn et al (133) have 
previously demonstrated the accurate correlation between thymidine kinase activity 
and [14C]thymidine incorporation as measures of DNA synthesis in rat hepatocytes. 
This data therefore confirms previous findings that peak [14C]thymidine 
incorporation occurs at 24 hours in animals of this approximate age (29). Elevated 
thymidine kinase activity at 72 hours probably represents a second wave of DNA 
synthesis. 
The pattern of mitotic activity observed in this group corresponded well with DNA 
synthesis, as it did in other experimental groups (see Chapters 8,9 and 12). It is 
possible that the true mitotic peak was somewhat greater than that recorded, since 
peak mitotic activity follows DNA synthetic activity by about 6 to 8 hours (32). The 
ODC peak at 4 hours confirmed the finding of McGowan and Fausto (186) that 
maximal ODC activity occurs at this time. Restoration of liver mass to that of sham-
operated animals occurred by 96 hours after partial hepatectomy, with the majority 
of growth occurring in the first 48 hours (see Table 7.2). A 3 fold elevation in 
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aspartate aminotransferase (AST) was demonstrated following partial hepatectomy, 
reaching a peak at 24 hours. This probably resulted from mechanical damage at the 
time of surgery. 
Having thus established the pattern of hepatic regeneration occurring after partial 
hepatectomy under constant conditions in our laboratory, we could proceed to 
compare the kinetics and magnitude of this response with changes in each of the 
experimental groups in turn. 
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8. HEPATIC ISCHAEMIA. 
To our knowledge, the question of hepatic ischaemia and its influence on the early 
regenerative process has not previously been examined. A single study in dogs (173) 
examined the liver mass 6 weeks after hepatic vascular occlusion and partial 
hepatectomy. In this component of the study we aimed to investigate the effect of 
warm hepatic ischaemia on hepatocyte proliferation and DNA synthesis in the first 
96 hours after partial hepatectomy. 
8.1 Methods. 
Midline laparotomy and partial hepatectomy (with modification as discussed on 
page 81) were performed. The bowel was retracted to the left and covered with a 
saline-soaked gauze swab. Great care was exercised throughout the procedure to 
keep the liver and intestines moist, and to minimize their handling. Liver dissection 
was then performed. Briefly, this was as follows: the falciform, left lateral and 
gastrohepatic ligaments were divided. The pyloric vein was ligated and divided, and 
the hepatic artery dissected free from the portal vein. Both left and right phrenic 
veins were divided and ligated. The oesophageal branches of the left gastric artery 
were diathermized and divided. The suprarenal inferior vena cava was dissected 
free from adjacent fatty connective tissue. The right adrenal vein was ligated and 
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divided. Remaining posterior attachments were freed. This dissection was 
performed in order to simulate the dissection of the recipient in the transplant 
procedure, and to ensure that no collateral blood supply reached the liver. 
Transient total hepatic ischaemia was then induced by clamping the hepatic artery, 
portal vein and bile duct for 40 minutes. The bile duct was clamped to ensure that 
no blood reached the liver via the biliary collateral vessels. During the period of 
ischaemia the liver appeared pale whilst signs of portal stasis became apparent. 
These included distension of the portal vein and its tributaries and cyanotic 
discolouration of the bowel. In all cases reperfusion was noted upon release of the 
clamps, with the liver and gut regaining their normal colour. 
India Ink test. The completeness of ischaemia was tested in a separate sample group 
in which 0.5 ml of Indian ink (diluted 50/50 in water) was injected into the dorsal 
vein of the penis following liver dissection and application of the clamps. Animals 
were sacrificed immediately thereafter and the liver examined histologically for 
evidence of carbon particle deposition in the Kupffer cells. Failure to demonstrate 
carbon particle accumulation would confirm firstly the adequacy of dissection and 
clamping, and secondly that retrograde filling via the hepatic veins had not occurred. 
See also Figure 8.1. 
8.2.1 Survival. 
8.2 Results. 
In this group 32 out of 76 animals survived until sacrifice ( 42% ). The adequacy of 
reperfusion was examined at autopsy. In none of the animals was failure of 
reperfusion apparent. Mortality was highest in the first 24 postoperative hours. 
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8.2.2AST. 
Plasma AST reached a maximum of 4 70 + -17 at 4 hours. Thereafter there was a 
sustained elevation persisting from 24 hrs ( 405 + -102) through to 48 hrs ( 443 + -45). 
This was followed by a gradual decrease to 301 + -45 at 72 hrs and 133 + -36 at 96 hrs. 
8.2.3 Thymidine kinase. 
Thymidine kinase levels were depressed at 4 hrs (2395 + -4 77) and at 24 hrs ( 6115 + -
2129). The recorded peak was demonstrated at 48 hrs (76804+-12340). Thereafter 
levels fell to 25047+-4178 at 72 hrs and 8535+-1701 at 96 hrs (Table 8.1). 
8.2.4 Mitotic index. 
Mitotic activity was depressed at 4 hrs (1 +-0) and at 24 hrs (1 +-0). Therafter a 
dramatic increase was noted to reach a level of 28 + -14 at 48 hrs. The mitotic index 
then declined to 11 + -3 at 72 hrs and 8 + -1 at 96 hrs (Table 8.1 ). 
Table 8.1 Thymidine kinase activity (dpm per mg protein) and mitotic index 
( mitotic figu,res per 1000 cells) inf asted rats after partial hepatectomy and 40 mins 
I . . I . ZPnatic 1{:r zaemia. 
TIME THYMIDINE KINASE MITOTIC INDEX 
4 hrs 2395 +-477 1 +-0 
24 hrs 6115+-2129 1+-0 
48 hrs 76804 +-12340 28+-14 
72 hrs 25047 +-4178 11 +-3 
96 hrs 8535 +-1701 8+-1 
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8.2.5 Liver mass index and tissue water. 
The liver mass index demonstrated a progressive increase with the greatest increase 
shown in the time period 48-96 hrs. Tissue water tended to be greater in the 
ischaemic livers than those subjected to partial hepatectomy only, although 
statistical significance was not reached (Table 8.2 and Table 7.2). 
Table 8.2 Liver mass index (LMI) and tissue water after partial hepatectomy and 
4() mim hPnatic i..:rhn"mia in fa..:t"d rats. 
TIME LIVER MASS INDEX TISSUE WATER 
4 hrs 0.399 + -0.054 74.3%+-2.3% 
24 hrs 0.514 + -0.033 71.6%+-0.7% 
48 hrs 0.577 + -0.029 73.1 % + -0.6% 
72 hrs 0.615 + -0.030 72.5 % + -0.5 % 
96 hrs 0.852 + -0.053 70.8%+-0.3% 
8.2.6 Omithine decarboxylase. 
Ornithine decarboxylase levels are demonstrated in Table 8.3. A gradual increase 
was shown with the recorded maximum ( 438 + -306) recorded at 72 hrs. 
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Table 8.3 Omithine decarboxylase (ODC) activity (cpm per mg protein) after 
oartial heoatertomv and 40 mins ischaemin in fmtPti rats. 
TIME ODC 
4 hrs 117 +-15 
24 hrs 197 +-51 
48 hrs 266+-86 
72 hrs 438+-306 
96 hrs 183+-116 
8. 2. 7 Histology. 
No hepatic carbon deposition was observed in the animals in which the India ink 
test was performed. In none of the sections studied was there evidence of massive 
hepatocyte necrosis. Intracellular accumulation of neutral fat, cellular hyperplasia 
and clumping of cytoplasmic basophilic material was noted. There was no consistent 
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Figure 8.1 Influence of 40 mins hepatic ischaemia without ponal decompression on 
hepatic regeneration in fasted rats. Partial hepatectomy was performed as a control ( clear 
bars) and compared to partial hepatectomy plus 40 mins hepatic ischaemia ( solid bars). 
Parameters of liver regeneration measured were the liver mass index ( LM!), thymidine 
kinase ( dpm per mg protein), mitotic index (mitotic.figures per 1000 cells) and omithine 
decarboxylase ( ODC) ( cpm per mg protein). Animals were sacrificed 4, 24, 48, 72 and 96 hrs 
after panial hepatectomy. Results were expressed as means+- SE. * p<0.05 and** p<0.01 
by ANOVA. tindicates TKfor solid bars at 48 hrs greater than TKfor clear bars at 24 hrs 
(p<0.05 by ANOVA). 
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8.3 Discussion. 
A delay in the time to reach a recorded peak in regenerative parameters was 
characteristic of the results for this group. The recorded maxima for the mitotic 
index and thymidine kinase activity were reached at 48 hours. The liver mass index, 
although reaching parity with partially hepatectomized controls by 96 hours, showed 
the greatest increment in the time period from 48 to 96 hours. By contrast, in 
partially hepatectomized controls, the peak thymidine kinase and mitotic activity 
was recorded at 24 hrs, and the LMI demonstrated greatest increases between 4 and 
48 hours. 
The cause of the delay in the initiation of the regenerative process merits further 
discussion. Briefly, this may be related either to nonspecific phenomena associated 
with the metabolic response to the surgical trauma of partial hepatectomy and 
ischaemia, or due to interference by ischaemia with specific hepatocyte proliferative 
control mechanisms. 
The first factor in regard to delay which requires consideration is the possibility that 
it is a false observation resulting from the sampling schedule, that is that the peak 
occurred somewhere between 24 and 48 hours. In an attempt to solve this, a small 
number of animals ( 6) was prepared in a side-arm of the study for sacrifice at 28 and 
32 hours. These samples also showed depressed levels of thymidine kinase and 
mitotic indices ( data not presented). Further extension of sampling which could be 
almost infinite, was deemed to be impractical. 
Another potential source of spurious results was investigated in a separate limb of 
the study ( data not presented): partially hepatectornized rats were exposed to 20 
rnins of inflow occlusion. In these animals, the liver had been fully mobilized. No 
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differences in the time course, or magnitude of liver regeneration could be 
demonstrated when these were compared to partially hepatectomized control 
animals (with no liver mobilization). These animals therefore served as a further 
control group to validate the differences observed between partially hepatectomized 
controls and animals exposed to 40 mins of inflow occlusion. 
Recently, a role for the sympathetic nervous system, noradrenaline and the alpha-1 
adrenergic receptor in the control of liver regeneration have been described ( 62). 
Sympathetic denervation by microsurgical dissection of the hepatic artery, or 
administration of the alpha-1 blocker prazosin, results in abolition of the 24 hour 
DNA synthetic peak in rats in vivo ( 62). The alpha-1 adrenoceptor has been shown 
to mediate the catecholamine effect, by downregulation of the EGF receptor and 
enhanced EGF mitogenic effects in primary hepatocyte culture (64). The delay in 
initiation of DNA synthesis seen in this group may therefore represent the results of 
hepatic sympathetic denervation, incurred at the time of the liver dissection, rather 
than any effect attributable to hepatic ischaemia or portal venous stasis. Cognizance 
should be taken of the fact that full hepatic dissection was not performed in partially 
hepatectomized controls. 
The initial depression of regenerative activity confirms the observations of Garcio-
Alonzo et al in rats exposed to ischaemia of up to 25 mins duration (96). A delay in 
the onset of the regenerative process following partial hepatectomy has also been 
observed in animals subjected to a simultaneous local inflammatory stimulus (11). 
In a study in rats, a focus of acute inflammation was induced by the injection of 
turpentine simultaneous to partial hepatectomy ( 11 ). This resulted in significant 
inhibition of the first peaks of hepatocyte DNA synthesis and mitosis (11). 
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In the current study, the hepatic ischaemia-reperfusion sequence may provide a 
comparable inflammatory stimulus. An invariable concomitant of local 
inflammation is an increase in tissue water in the form of oedema. The liver tissue 
water in those animals subjected to ischaemia tended to be higher than that of 
animals that had partial hepatectomy only. If this observation is valid, the increase 
in tissue water may represent a sequel to a local inflammatory response. The cause 
of the delay may be due to competition at the transcriptional or translational level 
for the synthesis of various proteins, with acute-phase proteins being synthesized in 
preference to those involved in cell proliferation. 
The imposition of an inflammatory stimulus upon the body usually results in the 
production of a broad range of acute phase proteins by the hepatocyte (11). This is a 
well documented phenomenon and part of the body's response to trauma. Removal 
of a segment of the liver sets into motion a burst of regenerative liver growth. If the 
animal is subject to a stressful stimulus simultaneous to the resection of part of the 
liver, then a reprogramming of function may occur which sees preference given to 
the production of acute phase proteins, later followed by a period in which 
regenerative proteins are synthesized. This could account for the delay in the 
initiation of the process in this and other groups. 
Acute phase proteins apart, the liver may be responsible for the synthesis of 
additional proteins at this time. When a cell is exposed to stressful situations, such 
as increased temperature or ischaemia, it begins to synthesize so-called heat-shock 
proteins to the relative exclusion of others (99). 
Like the acute phase proteins, heat-shock proteins are produced in response to a 
variety of noxious stimuli. This is suggestive of a protective effect. Despite obvious 
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similarities, these two phenomena appear to be distinct entities (see previous 
discussion). 
The expression of heat-shock proteins during hepatic regeneration has been 
demonstrated ( 46), with increased synthesis of both hsp83 and hsp70. A similar 
pattern occurs following the administration of hepatocarcinogens ( 46), which 
suggests their expression during both normal and abnormal hepatocyte 
proliferation. The circumstances of heat-shock protein synthesis are therefore 
similar to those observed for the expression of the c-H-ras amd c-myc oncogenes 
( 46). This would suggest a coordinate expression for these genes during liver 
regeneration. 
Apart from oncogenes, there are remarkable similarities in the expression of heat-
shock proteins and other proteins known to be associated with fetal and neoplastic 
growth, such as alpha-fetoprotein. The association of heat-shock proteins, c-H-ras 
and c-myc and alpha-fetoprotein with the regenerative response suggests that they 
might serve as useful clinical indicators of regeneration. The latter has been 
suggested as a noninvasive clinical test of regenerative activity in the clinical setting 
after transplantation ( 154 ). 
The biological significance of the heat-shock phenomenon is obscure. The 
expression of these proteins both during normal liver regeneration and following 
ischaemic injury to the liver suggest they may be of importance in the interpretation 
of the results of this study. An extension of this study could include the 
measurement of some of these proteins in the transplantation context. 
Further explanations for the observed delay in initiation of the regenerative process 
should be sought. Elevated corticosteroid levels have been observed following an 
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inflammatory stimulus (156). There is evidence for an inhibitory role for 
corticosteroids in liver regeneration (234 ). This would suggest that increased 
circulating corticosteroid hormones may account for the observed inhibitory effect. 
This explanation would however conflict with earlier studies in female rats in which 
prior surgical stress was shown to accelerate DNA synthesis (200). This apparent 
disparity in turn may be due to the sexual differences that occur in the response to 
irritative substances (140). Resolution of this question may only be feasible in 
primary hepatocyte culture, due to the multiplicity of factors complicating hormonal 
measurements in vivo. 
Fasting has also been shown to depress increases in DNA synthesis and mitotic 
activity following partial hepatectomy (200). However in this study all animals were 
fasted for 24 hours. 
ODC levels in this group were disorganized, with a peak being recorded at 72 hours. 
In a study of partially hepatectomized and hypophysectomized rats, McGowan and 
Fausto (186) demonstrated that although DNA synthesis was delayed by this 
procedure, the kinetics of polyamine metabolism were unaltered. This suggested 
that increased polyamine concentrations in partially hepatectomized liver may not 
be the trigger for the initiation of DNA replication. Our findings are strongly 
supportive of this contention, since the peak ODC activity in this group occurs well 
after maximal DNA replication has taken place. It is likely therefore that increased 
levels of polyamines are essential for cellular functions such as DNA synthesis, but 
that they do not constitute initiators of DNA synthesis in the prereplicative phase of 
cell division. This conclusion is however merely derived from the finding that the 
time course of ODC activity is not directly co-ordinated with the onset of DNA 
synthesis. 
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In addition to the delay in initiation of the regenerative process, apparent 
enhancement of hepatocyte proliferation was observed in animals subjected to 
hepatic ischaemia. Maximal DNA synthesis and mitotic activity were demonstrated 
at 48 hrs in this group. This was significantly greater than the peak response seen in 
the partially hepatectomized group at 24 hours. Although delayed, the proliferative 
response in this group was therefore enhanced. 
In the production of hepatic ischaemia by acute ligation of the porta hepatis, there is 
inevitable splanchnic stasis due to portal venous occlusion. This raises the question 
of whether the enhanced proliferative response is truly due to hepatic ischaemia or 
perhaps due to the sequelae of portal venous occlusion. This dilemma made 
necessary the creation of a model of hepatic ischaemia that obviated splanchnic 
stasis. This will be further discussed on page 109. 
DNA synthesis is enhanced after 90% partial hepatectomy (98). Hepatic ischaemia 
may result in ischaemic necrosis of hepatocytes. The possibility exists therefore that 
hepatic ischaemia results in an additional loss of functional hepatic parenchyma, 
with consequent enhancement of the regenerative stimulus. However in these 
animals which were subject to 40 minutes ischaemia, AST levels did not indicate 
significantly greater hepatocyte damage than in the animals with partial 
hepatectomy only. Furthermore, DNA synthesis was relatively diminished in those 
animals subject to hepatic ischaemia with portal venous decompression (see page 
105). This would counter the contention that ischaemia resulted in additional 
hepatocyte necrosis, and a greater regenerative stimulus. 
Portal venous occlusion of 30 minutes duration results in the appearance of 
endotoxin in the portal and systemic circulation (215). This may be accounted for by 
the translocation of endotoxin across the damaged intestinal mucosa (216). The 
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administration of exogenous endotoxin has been shown to enhance DNA synthesis 
significantly (266). Pretreatment with endotoxin 24 hours prior to partial 
hepatectomy accelerated DNA synthesis (61), and restriction of gut-derived 
endotoxin inhibited DNA synthesis following partial hepatectomy (60). The 
possibility exists therefore that the observed apparent enhancement in DNA 
synthesis and mitosis following portal venous occlusion may be accounted for by 
portal endotoxaemia. This effect may be mediated by cytokine release from 
endotoxin-activated Kupffer cells ( 43). Stimulation of DNA synthesis in hepatocytes 
by Kupffer cells has been demonstrated in vitro (146). Recently, Callery et al have 
demonstrated that Kupffer cell production of prostaglandin E2 is amplified during 
liver regeneration, whilst production of tumor necrosis factor-alpha is suppressed 
( 44 ). These observations serve to strengthen the functional relationship between 
activated Kupffer cells and the initiation of DNA synthesis in hepatocytes. 
In summary, the results from this group demonstrate that warm ischaemia 
significantly delays the first wave of DNA synthesis and mitosis in the partially 
hepatectomised rat liver. Furthermore, the magnitude of the regenerative response 
in this group is enhanced. A possible reason for this would be the activation of 
hepatic or gut macrophages by endotoxin, with resultant release of mitogenic 
cytokines. We have previously alluded to the necessity for a model of hepatic 
ischaemia that allows portal venous decompression. This is the subject of the 
following chapter. 
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9. HEPATIC ISCHAEMIA WITH PORTAL DECOMPRESSION. 
This component of the study aimed to investigate the effect of warm hepatic 
ischaemia, with portal venous decompression, on hepatocyte proliferation and DNA 
synthesis following partial hepatectomy. This was necessary in order to differentiate 
the effects of hepatic ischaemia per se from those of portal venous occlusion. 
9.1 Methods. 
Midline laparotomy and partial hepatectomy (as modified, see page 81) were 
performed. The bowel was retracted to the left and covered with a saline-soaked 
gauze swab. Great care was exercised to keep the liver and bowel moist, and to 
minimize their handling. Liver dissection was then completed as described on page 
90. 
Hepatic inflow occlusion was effected by application of vascular clamps to the 
hepatic artery, portal vein and bile duct. Further vascular clamps were applied to 
the suprahepatic IVC, infrahepatic IVC and distal portal vein. Using microvascular 
technique, a side-side portocaval shunt was made from the portal vein immediately 
distal to its confluence with the splenic vein to the infrahepatic vena cava. For this, 
10/0 nylon-70 m needle was used. A vascular clamp on the portal vein distal to the 
shunt converted this into a functional end-side shunt for the duration of the 
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ischaemic period. Time taken to perform the shunt was recorded in all cases. The 
mean duration of portal vein occlusion was 14 min +- 1 min, timed from the onset 
of inflow occlusion. The portocaval shunt was graded in terms of function (0 to 3/3). 
Parameters utilized in the grading were the absence of stenosis at the anastomotic 
site (1) and the visible admixture of portal and systemic blood (2). The normal 
appearance of the bowel was noted as an additional index of shunt patency (3). Only 
animals with shunts assessed as performing adequately (grade 3/3) were included in 
the study. On completion of the 40 minute ischaemic period the clamps were 
removed, and the portocaval shunt reversed by the application of a small-size "liga 
clip" (Ethicon) across the suture line. 
Figure 9.1 Diagram depicting the partially hepatectomized liver and the site of the 
portocaval shunt. 
lnfrahepatic IVC 
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9.2 Results. 
See Figure 9.2 for reference to partially hepatectomized controls. 
9.2.1 Survival. 
In this group 31 out of 40 animals survived until sacrifice (77% ). This compared 
favourably to the high mortality observed in those animals subject to partial 
hepatectomy and 40 rnins hepatic inflow occlusion without portal venous 
decompression ( 42% ). 
9.2.2AST. 
Plasma AST reached a maximum of 534 + -4 7 at 24 hrs after an initial elevation of 
424+-162 at 4 hrs. The elevation was sustained at 48 hrs (429+-50), but fell 
thereafter to reach levels of 199+-16 at 72 hrs and 100+-12 at 96 hrs respectively. 
This pattern was similar to that observed in partially hepatectornized animals and 
animals following partial hepatectomy and inflow occlusion, with no significant 
differences occurring at any sampling time. 
9.2.3 Thymidine kinase. 
Thymidine kinase levels were depressed at 4 hrs (12374+-9873) and at 24 hrs 
(9569+-3713). A modest peak was demonstrated at 48 hrs (22873+-6865). 
Thereafter levels gradually fell to 8804+-2907 at 72 hrs and 9305+-2536 at 96 hrs 
(Table 9.1). 
9.2.4 Mitotic index. 
No significant mitotic activity was recorded until 48 hrs in this group, with mitotic 
indices prior to this being diminished. The maximum recorded value occurred at 48 
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hrs (17+-3), with mitotic activity persisting until 72 hrs (16+-5). By 96 hrs levels had 
fallen to 8+-1 (Table 9.1). 
Table 9.1 Thymidine kinase activity (dpm per mg protein) and mitotic index 
( mitotic figures per 1000 cells) inf asted rats after partial hepatectomy and 40 mins 
hepatic ischaemia with portal decompression. 
TIME THYMIDINE KINASE MITOTIC INDEX 
4 hrs 12 374+-9 873 1 +-0 
24 hrs 9 569+-3 713 2+-2 
48 hrs 22 873 + -6 865 17+-2 
72 hrs 8 804+-2 907 16+-5 
96 hrs 9 305+-2 536 8+-1 
9.2.5 Liver mass index and tissue water. 
The liver mass index is shown in Table 9.2. There was a progressive increase in liver 
mass, with the greatest increase shown in the second 48 hour period. Tissue water 
increased in the period from 24 hrs to 72 hrs. 
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Table 9.2 Liver mass index (LM/) and tissue water after partial hepatectomy and 
40 mins hepatic ischaemia with portal decompression inf asted rats. 
TIME LIVER '.'AASS INDEX TISSUE WATER 
4 hrs 0.434 + -0.025 70.5%+-0.7% 
24 hrs 0.439 + -0.037 72.8%+-1.7% 
48 hrs 0.581 +-0.029 73.1 % + -0.4% 
72 hrs 0.734+-0.031 72.2% +-0.2% 
96 hrs 0.912 +-0.029 70.7%+-0.5% 
9.2.6 Omithine decarboxylase. 
Ornithine decarboxylase activity was disorganised, with maximal activity shown at 96 
hrs (Table 9.3). 
Table 9.3 Omithine decarboxylase (ODC) activity (cpm per mg protein) after 
partial hepatectomy and 40 mins ischaemia with portal decompression inf asted rats. 
TIME ODC 
4 hrs 77+-11 
24 hrs 70+-17 
48 hrs 111+-21 
72 hrs 117+-20 
96 hrs 389+-324 
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Figure 9.2 Influence of 40 mins hepatic ischaemia with ponal decompression on hepatic 
regeneration infasted rats. Partial hepatectomy was performed as a control (clear bars) and 
compared to partial heparectomy plus 40 mins hepatic ischaemia ( solid bars). Parameters of 
liver regeneration measured were the liver mass index (IM/), thymidine kinase ( dpm per mg 
protein), mitotic index(mitoticfigures per 1000 cells) and omithine decarboxyiase (ODC) 
( cpm per mg protein). Animals were sacrificed 4, 24, 48, 72 and 96 hrs after panial 
hepatectomy. Results were expressed as means+- SE. * p<0.05 and** p<0.01 by ANO VA. 
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9.3 Discussion. 
Rationale for the use of the portocaval shunt. 
In the production of hepatic ischaemia by acute ligation of the porta hepatis, there is 
inevitable splanchnic stasis due to portal venous occlusion. It is necessary therefore 
to differentiate between hepatic ischaemia and splanchnic stasis as possible causes 
for the observed effects. Hence the need for a model of hepatic ischaemia that 
obviates splanchnic stasis. 
In previous studies, this question has been resolved by use of the model described by 
Baker (5). This involves the temporary ligation of the hilar pedicle of the left lateral 
and median lobes, with the remaining portal tributaries left intact to allow drainage 
of the portal venous system (38,191). The perfused posterior lobes are then excised, 
with the result that ischaemia is produced in the left lateral and median lobes 
without the occurrence of portal stasis. For direct comparison to other groups in this 
study, it would have been necessary to perform this technique in reverse, in order to 
preserve the posterior lobes and resect the left lateral and median lobes as in 68% 
partial hepatectomy (116). This was not a feasible consideration, due to technical 
difficulty associated with the accurate dissection of the posterior lobar branches of 
the hepatic artery. The importance of the latter dissection is in the adequacy of 
sympathetic denervation at this time. This is discussed in detail on page 119. 
A further possibility is the construction of a portafemoral shunt using polyethylene 
tubing ( 179). However, extracorporeal shunts have been found to be cumbersome 
and associated with numerous technical problems (161). These include shunt 
occlusion, increased bloodloss and increased operative time (161). Although 
extracorporeal portosystemic shunting would have closely matched the clinical 
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situation, we thought it impractical in view of the problems encountered in its 
previous use. 
Discussion of results. 
Unlike the group in which hepatic ischaemia was associated with portal stasis, in 
these animals the proliferative response was delayed only. At 48 hours a modest 
peak in thymidine kinase activity as well as mitotic index was demonstrated. This 
was significantly less than the corresponding peak for animals with ischaemia and 
portal stasis. However, it is important to note that it was not statistically different 
from the peak in partially hepatectomized animals at 24 hours. Hence the nett effect 
was one of delay only, with no attenuation of the proliferative response as compared 
to partially hepatectomized controls. 
Since the delay in the initiation of DNA synthesis and cytokinesis was observed in 
all animals in which hepatic ischaemia occurred, irrespective of portal stasis, it is 
likely that the cause of this is unrelated to portal venous congestion or its sequelae. 
Two thirds partial hepatectomy in the rat results in a highly reproducible 
regenerative response if the animal and the liver are normal (31 ). Hepatocyte 
growth appears to be controlled by complex interacting mechanisms to which 
changes in the cell cycle (239), tissue and plasma enzymes (229), and plasma 
hormones (91) all contribute. In general, manipulations have resulted in stimulation 
of the response but inhibition has also been described and in a few cases, delay has 
been noted. To date, only the effects of warm ischaemia upon the regenerative 
response have been studied (96), but not in the context of transplantation of 
reduced livers. Depression of the regenerative response at 24 hours was reported 
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after ischaemia of 25 minutes' duration but the subsequent pattern was not 
mentioned (96). 
Although the increase in liver mass was delayed by 24 hours in this group, by the 
end of the experimental period (96 hours) there was no difference in liver mass of 
these rats as compared to partially hepatectomized controls. Also of note was that 
there was no difference in plasma levels of aspartate aminotransferase (AST). 
There are several descriptions in the literature of manipulations which result in 
delay of the regenerative response, as distinct from inhibition. The most likely of 
these is the denervation associated with dissection. Denervation or blockade of 
alpha-1 adrenergic receptors has been shown to attenuate the 24 hour peak of DNA 
synthesis, although this demonstrates a return to within normal limits by 72 hours 
( 62). This possibility made necessary the extension of this study to include the 
examination of hepatic dearterialization in a separate group of animals. The results 
of this are discussed at length in Chapter 10. 
Another possibility is that DNA synthesis is inhibited by high circulating levels of 
glucagon which have been shown to prolong the transition from the G 1 to S phase 
(256). The immediate effects of portal occlusion upon plasma levels of glucagon do 
not appear to have been studied but certainly, plasma glucagon levels are elevated 
significantly within thirty minutes of portacaval shunting ( 115). This may account for 
the delay in this group of animals in which temporary portocaval shunting is 
performed. Other substances which interfere with the activity of ornithine 
decarboxylase, such as gamma-amino-isobutyric acid (195) do not appear to have 
been measured after portal occlusion. 
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In his original studies, Rappaport showed the subdivision of the liver into functional 
units around the branches of the portal vein and the hepatic artery (243). 
Subsequently, Rabes et al suggested that location with respect to microvascular and 
actual functional state appear to be the decisive factors in the initiation of DNA 
synthesis in individual hepatocytes (235). It has been shown that the zone of 
maximal proliferation proceeds through the unit to the perivenous area; a second 
wave occurs at 56 hours (235,263). It is speculated that the first wave begins in the 
periportal area because of hepatotrophic factors in portal blood. While such 
hepatotrophic factors have not been positively identified, it is possible that levels of 
some substance may be depressed after portal vein occlusion or that periportal 
hepatocytes may be rendered temporarily unresponsive to such substances. There 
are several possibilities in this regard. Significant changes in the hepatic 
rnicrocirculation after portal venous clamping have recently been described, 
including activation of hepatic macrophages and increased leucocyte adhesion ( 184 ). 
It has been stated that "portal venous clamping during transplantation surgery may 
have an impact on the hepatic microcirculation and cell-to-cell interaction due to 
endotoxin mediated activation of various inflammatory cascades and cell 
populations" ( 184 ). During portal venous occlusion there may be depressed synthesis 
of epidermal growth factor in the Briinner's glands which would impair DNA 
synthesis (155); also disturbance of other cytokines including transforming growth 
factor beta (253) or interleukin 1 beta (208) would lead to disorganisation of the 
replicative response. This pattern seems to involve reprogramming of gene 
expression with competition at the transcriptional or translational level which allows 
synthesis of acute phase proteins first and then replication. Animals subjected to 
partial hepatectomy with a simultaneous local inflammatory stimulus also show a 
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delay which is attributed to the same mechanism (11) and in the present studies, the 
ischaemia-reperfusion sequence may provide such an inflammatory response. 
The response of liver cells to damage or removal appears to be proportional to the 
amount of mass removed and it has been noted that removal of 80% of the liver 
mass results in delayed DNA synthesis (300). Also, administration of allyl formate to 
animals which have been subjected to partial hepatectomy causes cells nearer the 
hepatic veins to replicate (238). The addition of ischaemia to partial hepatectomy 
may have resulted in similar increased damage but this was not evident from the 
plasma levels of AST. 
The apparent increase in liver mass without the associated increase in cell number 
may be the result of hypertrophy of cells. Infusion of hydroxyurea prevents liver cells 
moving from the G 1 to the S phase of the cell cycle and causes cells to accumulate 
in that part of the cycle. Since they cannot respond with hyperplasia, cells appear to 
undergo hypertrophy (236). Confirmation that this is the cause of increased liver 
mass would be obtained from cell morphometry. Indeed, detailed analysis of 
changes in the events of the cell cycle would probably clarify the precise 
mechanisms for the observed delay. 
Tissue levels of ornithine decarboxylase were measured as an additional index of 
cell replication. The peak of ODC activity was at 96 hours in this group, but was not 
significantly greater than controls, and demonstrated a wide standard error. Partially 
hepatectomized control animals demonstrated a peak of ODC activity at 4 hours, in 
keeping with other studies (186). Polyamine metabolism appeared disorganised 
therefore. Although it has been stated that the sequential appearance in the blood 
of ODC and thymidine kinase is typical of liver regeneration and is consistent for 
each species, the time course of ODC activity has been shown to be independent of 
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the onset of DNA replication in regenerating livers (186) and it seems that this 
component of the response is particularly sensitive to manipulations. 
The attenuation of the proliferative response in this group may be due to the 
avoidance of a protracted period of portal stasis. Although endotoxin levels were 
not measured, it is apparent from previous studies that systemic and portal 
endotoxaemia follows a period of portal venous occlusion in rats (215). Furthermore 
endotoxin has been strongly implicated in the stimulation of hepatocyte 
proliferation (60,61,266). It is not known however, if the avoidance of portal stasis 
entirely prevents this endotoxaemia. 
As previously discussed on page 101 it is unlikely that the observed effect can be 
attributed to ischaemic hepatocyte damage with greater loss of functional 
hepatocyte mass. Aspartate aminotransferase levels in this group followed the 
pattern of partially hepatectomized controls, with no significant differences at any of 
the time points studied. 
In summary then, the possible reasons for the delay in the initiation of the 
regenerative response in this and previously discussed groups of animals are 
therefore likely to be: 
1. Sympathetic denervation following dissection of the sympathetic plexus 
around the hepatic artery. 
2. Diversion of hepatic synthetic function to the synthesis of acute phase 
proteins. 
3. Consequent to the elevation of corticosteroid levels associated with the 
metabolic response to surgical trauma. 
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Diversion of hepatic synthetic function to the production of heat shock 
proteins. 
5. Related to hyperglucagonaemia occurring after portocaval shunting. 
The results from this and the previous group demonstrate that warm ischaemia 
significantly delays the first wave of DNA synthesis and mitosis in the partially 
hepatectomised rat liver. Furthermore, the magnitude of the regenerative response 
is attenuated by portal venous decompression, with respect to those animals in 
which portal stasis occurred. A possible reason for this would be the avoidance of 
portal and systemic endotoxaemia associated with portal stasis. 
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10. HEPATIC ARTERIAL LIGATION. 
The purpose of this group was to establish whether the alterations in hepatocyte 
proliferation kinetics observed in animals exposed to liver dissection were 
attributable to hepatic denervation. 
10.1 Methods. 
Midline laparotomy and partial hepatectomy (with modification) were performed. A 
full liver dissection was then completed. Briefly, this was as follows: the falciform, 
left lateral and gastrohepatic ligaments were divided. The pyloric vein was ligated 
and divided, and the hepatic artery dissected free from the portal vein. Both left and 
right phrenic veins were divided and ligated. The oesophageal branches of the left 
gastric artery were diatherrnized and divided. The suprarenal inferior vena cava was 
dissected free from adjacent fatty connective tissue. The right adrenal vein was 
ligated and divided. Following the complete freeing of all remaining attachments to 
the liver, the portal vein and superior and inferior vena cavae were meticulously 
stripped of adventitial tissue using microsurgical technique. The hepatic artery was 
ligated and double-tied using 6/0 silk. All adventitial tissue around the hepatic 
artery was dissected free. 
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10.2 Results. 
10.2.1 Survival. 
There was 100% survival to sacrifice in this group (n=5). 
10.2.2AST. 
A marked increase in plasma AST was noted, with levels reaching 691 +-43 by 24 
hours. This was not significantly different from that observed in partially 
hepatectomized controls, or for either of the ischaemic groups. It was however 
significantly less (p < 0.05) than the AST elevation observed in stored allografts at 
this time (see page 137). 
10.2.3 Thymidine kinase. 
Thyrnidine kinase activity in this group was recorded as 36308 + -6063. This was of 
similar magnitude to the peak observed in the ph control group (36021 +-8060) (see 
page 83). 
10.2.4 Mitotic index. 
The mitotic index of 5 + -3 at 24 hrs did not correlate accurately with thyrnidine 
kinase activity in this group, and was less than that of ph controls (25 + -8) (p < 0.01 ). 
10.2.5 Liver mass index and tissue water. 
The liver mass index recorded at 24 hours was 0.4 76 + -0.33. This was not 
significantly different from partially hepatectomized controls. Tissue water at 24 hrs 
was 70% + -0.8%, and no different from controls (Table 7.2). 
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Figure 10.1 Influence of hepatic dearterialization on hepatic regeneration in f
asted rats. 
Partial hepatectomy was pe,formed as a control (solid bars) and compared 
to partial 
hepatectomy plus hepatic arterial ligation ( clear bars). Parameters of liver
 regeneration 
measured were the liver mass index ( LMJ), thymidine kinase ( dpm per mg p
rotein) and 
mitotic index (mitotic figures per 1000 cells). Aspartate aminotransferase (
AST) was 
measured in plasma, and expressed in International Units (JU). Animals w
ere sacrificed 24 
hrs after partial hepatectomy. Results were expressed as means+- SE. * p<0
.05 by ANO VA. 
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10.3 Discussion. 
Thymidine kinase activity at 24 hours in dearterialized, partially hepatectomized 
animals paralleled the peak activity in partially hepatectomized animals at this time. 
The liver mass index was similar to that of controls, suggesting a comparable rate of 
regenerative growth. However, the mitotic activity was significantly diminished with 
respect to ph controls. This represented a disparity between regenerative activity as 
indexed by thymidine kinase and that reflected by cellular division. Since both DNA 
synthesis and liver mass were comparable to controls, the low level of mitotic 
activity may not reflect a truly blunted response. The reasons for this are unclear 
however. 
A previous study of liver mass gain after hepatic arterial ligation and 
hemihepatectomy in dogs demonstrated normal liver mass increase as compared to 
hemihepatectomized controls (301). This suggested that arterial inflow has little 
influence on the course of liver regeneration, as measured by increase in liver mass, 
and size on liver scan. It was also demonstrated that hepatic necrosis did not follow 
the permanent ligation of the hepatic artery (301). Our findings in rats are therefore 
confirmatory of these observations. Furthermore, in the latter study it was shown 
that hepatic arterial perineurectomy without hepatic arterial ligation had no effect 
on the course of liver regeneration, as measured by increase in liver mass and size 
(301). The results of other studies of hepatic arterial ligation have demonstrated 
considerable variation in the degree of hepatic necrosis and mortality, with large 
interspecies variations (231 ). 
Recently, a role for the sympathetic nervous system, noradrenaline and the alpha-1 
adrenergic receptor in the control of liver regeneration has been described (62). 
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Sympathetic denervation by microsurgical dissection of the hepatic artery, or 
administration of the alpha-1 blocker prazosin, results in abolition of the 24 hour 
DNA synthetic peak in rats in vivo (62). The alpha-1 adrenoceptor has been shown 
to mediate this catecholamine effect, by downregulation of the EGF receptor and 
enhanced EGF mitogenic effects in primary hepatocyte culture (64). 
The results in our study are therefore contradictory to those of Cruise et al ( 62), in 
that no difference in the regenerative response at 24 hours in dearterialized animals 
could be demonstrated. Sympathetic denervation may diminish the release of 
catecholamines from sympathetic nerve terminals, but will not prevent exposure of 
adrenergic receptors to circulating catecholamines. The administration of an alpha-
1 blocker would obliterate any effect due to circulating catecholamines, as observed 
by Cruise et al ( 62). 
It is important to note that any differences observed in this group may have been 
due either to hepatic denervation or due to hepatic arterial ligation. It was felt 
necessary to completely ligate the hepatic artery in order to assure that no 
sympathetic innervation persisted. Since there was no demonstrable difference in 
the regenerative response between these animals and partially hepatectomized 
controls, the cause of the delay in initiation of hepatocyte proliferation in those 
animals subjected to full hepatic dissection in other groups is therefore unlikely to 
be due to hepatic denervation. 
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11. IN SITU LIVER FLUSHING. 
The role of nonparenchymal cells in both regeneration (20) and transplantation 
(183,189) has been the focus of recent study. During the transplantation procedure, 
it is possible that the nonparenchymal cell population may incur an injury resulting 
from flushing of the liver prior to storage. This part of the study aimed to ascertain 
the effect of such flushing on the regenerative response under conditions likely to 
occur in clinical transplantation. 
11.1 Methods. 








ph + Ringer's lactate flush at 37 C (n=6); 
0 
ph + Ringer's lactate flush at 4 C (n=30); 
0 
ph + University of Wisconsin flush at 4 C (n = 32); 
0 
ph + Euro-Collins' solution flush at 4 C (n=31); 
Midline laparotomy and partial hepatectomy were performed as described on page 
81. Full hepatic dissection as described on page 90 was not performed. The liver was 
isolated by clamping the following structures in order: bile duct, hepatic artery, 
portal vein, infrahepatic inferior vena cava and suprahepatic vena cava. A primed 
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isolated by clamping the following structures in order: bile duct, hepatic artery, 
portal vein, infrahepatic inferior vena cava and suprahepatic vena cava. A primed 
cannula was passed into the portal vein distal to the clamp and secured. A venotomy 
was made in the infrahepatic suprarenal inferior vena cava distal to the clamp using 
a 23G needle. Prograde flushing of the liver was commenced. A total of 10 ml was 
used to flush the isolated liver, with the composition of the first 5 ml varying 
according to the experimental group. The subsequent 5 ml flush utilised Ringer's 
solution in all cases. In a pilot study, a volume of 10 ml was found to be sufficient to 
reduce the haematocrit of the vena caval effluent to less than 1 % (n = 6). The 
temperature of the flushing solution was as stated. The haematocrit of the vena 
caval effluent was recorded in a representative sample of animals (n= 10), and never 
exceeded 2%. Perfusion pressure was standardized by manometry. This employed a 
column of water connected by a T-piece to the flushing catheter. Perfusion pressure 
was maintained at less than 30cm water in all cases. On completion of the liver 
flush, the portal vein and inferior vena caval venotomies were repaired using 9 /0 
nylon-140 m needle, and the clamps removed. The total ischaernic time to perform 
the liver flushing was recorded, and never exceeded 5 minutes. 
11.2 Results. 
11. 2.1 Survival. 
Of the 109 animals in groups II-IV, 99 survived until sacrifice (91 % ). The 10 animals 
that died were evenly distributed amongst the' three groups, with no discernible 
cause evident at autopsy. The mortality of group I animals is presented on page 82. 
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ll.2.2AST. 
There was no significant difference between the experimental groups, nor were the 
AST values significantly elevated over partially hepatectomized controls (Table 
11.1). AST levels in group II animals (914+-133) were of similar magnitude to those 
in other groups at 24 hours. 
11.2.3 Thymidine kinase. 
Thymidine kinase levels in groups II, III, IV and V were diminished at 24 hrs with 
respect to controls (p<0.01). The recorded peak occurred at 48 hrs in all groups, 
with the highest value occurring in the UW flush group (Figs. 11.1-11.3). 
11.2.4 Mitotic index. 
The mitotic index in groups II, III, IV and V was diminished at 24 hrs with respect to 
controls (p < 0.05). The recorded peaks occurred at 48 hrs in all groups in parallel 
with the elevation in thymidine kinase activity demonstrated at this time. In group 
IV (UW flush) this was significantly greater than the mitotic index in group I (ph) at 
48 hrs (p<0.01) (Figs. 11.1-11.3). 
11.2.5 Liver mass index and tissue water. 
The liver mass indices were diminished in groups II, III, IV and V at 48 hrs 
(p < 0.01). By 72 hrs there were no significant differences in the liver mass index 
between any of the groups and sham-operated animals (Figs. 11.1-11.3). No 
differences in tissue water could be demonstrated between the groups. 
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11.2.6 Omithine decarboxylase. 
ODC was depressed in group V at 4 hrs (p < 0.05), whilst in groups III and IV it 
tended to be less than that of group I (ph). There were no significant differences in 
ODC at the remaining sampling periods in any of the groups studied (Figs. 11.1-
11.3). 
11.2. 7 Haematocrit. 
The haematocrit of the vena caval effluent after 10 ml flush was less than 2% in a 
representative sample group (n= 10). 
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Table 11.1 Influence of in situ liver flushing on aspartate aminotransferase (AST) in 
fasted rats. Partial hepatectomy was perfonned as a control (PH) and compared to 
Ringers Lactate flush (RL flush), UW /RL flush (UW flush) and Euro-Collins/RL flush 
(EC flush). 
T1~E PH RL FLUSH UW FLUSH EC FLUSH 
4 hrs 328+-40 545+-46 370+-71 508+-106 
24 hrs 390+-31 377+-90 982+-388 553+-69 
48 hrs 237 +-16 370+-42 562+-169 487+-39 
72 hrs 192+-32 163+-19 280+-52 159+-28 
96 hrs 111 +-9 188+-52 135+-25 102+-15 
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Figure 11.1 Influence of liver flushing with Ringer's lactate solution on hepatic 
regeneration in fasted rats. Partial hepatectomy was performed as a control (first bar) and 
0 
compared to partial he patectomy plus Ringer's solution flush at 4 C ( second bar) and 
0 
Ringer's solution flush at 37 C (third bar). Parameters of liver regeneration measured were 
the liver mass index ( !Ml). thymidine kinase ( dpm per mg protein), mitotic index ( mitotic 
figures per 1000 cells) and ornithine decarboxylase (ODC) (cpm per mg protein). A.nimals 
were sacrificed 4, 24, 48, 72 and 96 hrs after partial hepatectomy. Results were expressed as 
means+- SE. * p<0.05 and** p<0.01 by ANOVA. 
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Figure 11.2 Influence of liver flushing with University of Wisconsin solution on hepatic 
regeneration infasted rats. Partial hepatectomy was performed as a control (solid bars) and 
0 
compared to partial hepatectomy plus University of Wisconsin.flush at 4 C ( clear bars). 
Parameters of liver regeneration measured and times were as for Fig.I I .I Results were 
expressed as means+- SE. * p<0.05 and** p<0.01 by ANOVA. 
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Figure 11.3 Influence of liver flushing with Euro-Collins solution on hepatic regeneration 
infasted rats. Partial hepatectomy was performed as a control (solid bars) and compared ro 
partial hepatectomy plus Euro-Collins solution flush at 4 ° C ( clear bars). Parameters of lfre r 
regeneration measured and times were as for Fig.11.1 Results were expressed as means+-
SE. * p<0.05 and** p<0.01 by ANOVA. 
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11.3 Discussion. 
The results of this component of the study indicate that the first wave of DNA 
synthesis and hepatocyte mitotic activity was inhibited by in situ flushing of the liver 
with either Ringer's Lactate, Euro-Collins or University of Wisconsin solutions. This 
was shown by the significantly diminished thymidine kinase activity and mitotic 
indices at 24 hours. Compared with the peak in ODC activity occurring at 4 hours in 
partially hepatectomized animals, ODC activity in each of the experimental groups 
was either significantly diminished (group V) or tended to be less (groups III and 
IV) at this time. Further evidence of the delay in initiation of the regenerative 
process in all experimental groups was a significantly diminished liver mass index at 
48 hours. This finding was similar to other experimental groups (partial 
hepatectomy plus ischaemia or autograft) in which a delay in the initiation of the 
process was demonstrated. However, liver regeneration seemed unaffected in the 
longer term. By 72 hrs the liver mass had been restored to that of sham-operated 
animals in all groups. 
Of note was the elevation in mitotic activity in group IV (UW flush) at 48 hours. 
This was not associated with a simultaneous increase in thymidine kinase activity at 
this time, nor was there a significant difference in ODC activity. Taken together, the 
elevated mitotic activity in this group seems unlikely to represent a truly enhanced 
regenerative response over the other groups in which the liver was flushed. 
Aspartate aminotransferase has been established as a useful marker of liver graft 
viability ( 124 ). Significantly, AST levels in the animals in which liver flushing was 
performed were no greater than in partially hepatectomized animals. This would 
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suggest that any damage imposed during the flushing procedure was confined to the 
microvasculature, with no significant hepatocyte damage. 
The role of the nonparenchymal and endothelial cells in maintenance of normal 
liver function following transplantation is being recognized increasingly (183). The 
control of liver regeneration may be governed by a paracrine mechanism involving 
the synthesis of TGF beta by nonparenchymal cells. Damage to these cells by 
preservation could influence the the regenerative response. Evidence for the role of 
TGF beta is provided by the finding that TGF beta, a Kupffer cell product, is able to 
inhibit the mitogenic effects of TGF alpha in primary hepatocyte culture (20). 
Sinusoidal lining cells are involved in the storage lesion during liver preservation 
(189). The observed delay in the initiation of the regenerative process may therefore 
reflect alteration in nonparenchymal cell function, following damage imposed 
during the flushing procedure. However, reperfusion injury appears to be confined 
to the endothelial cells with relative sparing of the Kupffer cells ( 41 ). 
Increasead survival has been reported in liver grafts after rinsing with warm Ringer's 
Lactate, with associated lower AST values and improvement in microcirculation 
(289). The results of group II, in which in situ liver flushing was performed using 
0 
Ringer's Lactate at 37 C did not demonstrate significantly different results to those 
in which cold flushing was utilized. In this group the thymidine kinase activity and 
mitotic index were diminished at 24 hrs, as in groups III, IV and V. This suggests 
that hypothermia per se is not responsible for the observed results. 
The causes of a delay in the initiation of the regenerative process have been 
previously discussed on page 96, and will not be repeated here. Irrespective of the 
cause of the initial delay, the regenerative response was established by 72 hrs in all 
groups, as indicated by the restitution of liver mass. 
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In conclusion there appears to be no long-term effect of liver flushing on hepatocyte 
DNA synthesis or cytokinesis. In Chapter 12 we will extend our investigation beyond 
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PARTIAL ORTHOTOPIC LIVER AUTO- AND 
ALLOTRANSPLANTATION. 
In the transplant procedure, several insults are imposed on the liver which may have 
a bearing on its normal physiologic processes. These have been identified as warm 
and cold hepatic ischaemia, reperfusion injury, flushing of the liver and its possible 
effects upon endothelial cells, the effects of portal venous stasis, liver preservation, 
denervation, and the ill-defined effects of the procedure itself. Where possible, it 
was endeavoured to isolate these factors in order that they might be examined 
individually. The liver transplant procedure combines several of these factors and it 
was the purpose of this component of the study therefore to examine the overall 
effect of the combination on the regenerative capacity of the partial liver transplant. 
12.1 Methods. 
12.1.1 Orthotopic reduced liver autograft. 
Midline laparotomy was performed, followed immediately by partial hepatectomy 
(with modification). The bowel was retracted to the left and covered with a saline-
soaked gauze swab. A similar swab was placed on the liver. Great care was exercised 
throughout the procedure to keep the liver and intestines moist, and to minimize 
their handling. Liver dissection was then completed. Briefly, this was as follows: the 
twelve partial auto- and allotransplantation 133. 
falciform, left lateral and gastrohepatic ligaments were divided. The pyloric vein was 
ligated and divided, and the hepatic artery dissected free from the portal vein. The 
gastroduodenal branch of the hepatic artery was cauterized in order that the 
subsequent anastomosis could be performed proximal to its origin. Both left and 
right phrenic veins were divided and ligated. The oesophageal branches of the left 
gastric artery were cauterized and divided. The suprarenal inferior vena cava was 
dissected free from adjacent fatty connective tissue. The right adrenal vein was 
ligated and divided. Remaining posterior attachments were freed. 
Heparin was administered in a dose of 12 IU sodium heparin/kg (made up to 1ml in 
0.9% NaCl) by single injection into the dorsal vein of the penis immediately prior to 
application of the clamps. The bile duct was ligated and a polyethylene stent 
inserted and secured into the proximal portion. Vascular clamps were then applied 
to the hepatic artery, portal vein and infrahepatic vena cava and these were then 
transected in this order. Caution was observed in the placement of the clamps in 
order that sufficient length be preserved for the subsequent anastomosis. To obtain 
an adequate cuff of suprahepatic vena cava, a modified haemostat was applied 
across the vein including a portion of the diaphragm, and the vein divided at the 
liver margin. The liver was lifted out of the abdomen to ensure that no attachments 
remained, and replaced in the orthotopic position. Re-implantation was then begun 
with the vessels sutured in the order of suprahepatic IVC, portal vein, infrahepatic 
IVC and hepatic artery. 
After completion of the suprahepatic vena caval and portal venous anastomoses, the 
clamps on these vessels were released and hepatic reperfusion was allowed to occur. 
Ischaernic time was recorded in all cases. The mean duration of portal vein 
occlusion was 22 rnins + - 1 min. The infrahepatic vena cava was then sutured. The 
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portal vein, supra- and infrahepatic vena cavae were all sutured by direct end-to-end 
anastomosis. Microvascular technique was employed using 8/0 nylon-140 m needle 
for the suprahepatic IVC and 9/0 nylon-140 m needle for the infrahepatic IVC and 
portal vein. The hepatic artery anastomosis was performed using the sleeve 
technique (66) and 10/0 nylon-70 m needle. This technique is a form of end-in-end 
anastomosis which utilizes only 2 sutures. Long-term patency of the hepatic arterial 
anastomosis in rat liver allografts using this technique has been documented (113). 
Finally, bile duct continuity was re-established over the polyethylene stent and 
secured with a 7 /0 silk tie. The stent was then left in situ. Delivery of anaesthetic gas 
(ether) was diminished during the anhepatic phase in accordance with the decreased 
anaesthetic requirements of the animal at this time. 
12.1.2 Orthotopic reduced liver allograft. 
a) Donor procedure. 
Midline laparotomy was performed, followed immediately by partial hepatectomy 
(with modification). The liver dissection was performed as described for the 
orthotopic autograft. The bile duct was then transected and a polyethylene cannula 
inserted into the proximal portion and secured. The animal was fully heparinised 
using 12 IU sodium heparin/kg (made up to 1ml in 0.9% NaCl) by single injection 
into the dorsal vein of the penis immediately prior to application of the clamps. 
Vascular clamps were applied to the proximal portal vein, hepatic artery, 
suprahepatic IVC and infrahepatic IVC. A primed cannula was inserted into the 
portal vein via a venotomy and secured. Cold perfusion of the liver was then 
0 
commenced using 5 ml of University of Wisconsin solution at 4 C. The effluent was 
allowed to drain through a venotomy in the inferior vena cava between the clamps. 
The vessels were then transected and the liver harvested for storage. 
twefre parlial auto- and allotra11spla11tatim1 135. 
b) Storage. 
The flushing cannula was secured in the portal vein and the liver placed in Ringer's 
0 
lactate solution for storage at 4 C. A plastic container holding the liver in Ringer's 
lactate was placed in a second container of slushed ice, and this in turn placed in a 
0 
refrigerator at 4 C. All livers used in this study were stored for 4 hrs. On completion 
of storage, and immediately prior to re-implantation, the liver was flushed with 5 ml 
0 
of Ringer's lactate solution at 4 C. 
c) Recipient procedure. 
The mass of the recipient animal was chosen to closely approximate the mass of the 
donor. The preparation of the recipient was timed in order that re-implantation 
would take place 4 hrs after harvesting of the donor liver. Laparotomy, full 
heparinisation and dissection of the liver were performed as in the donor animal. 
Vascular clamps were applied to the portal vein, hepatic artery and infrahepatic 
vena cavae. The structures of the portal triad were transected at the hilum of the 
liver, in order to preserve length. To obtain an adequate cuff of suprahepatic vena 
cava, a modified haemostat was applied across the vein including a portion of the 
diaphragm, and the vein divided at the liver margin. The native liver was lifted from 
its position and discarded. The donor liver was placed in the orthotopic position and 
implantation commenced. The suprahepatic vena caval anastomosis was sutured 
first by direct end-to-end anastomosis using 8/0 nylon-140 m needle. The portal vein 
was completed next using the same technique and 9 /0 nylon-140 m needle. The 
mean duration of portal vein occlusion was 21 min + - 1 min. On completion of the 
suprahepatic vena caval and portal venous anastomoses, the clamp on the portal 
vein was released. The liver gradually resumed its normal colour as it was perfused 
with portal blood. The first 1 ml of hepatic venous effluent was allowed to drain 
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from the infrahepatic vena cava, following the temporary removal of the clamp. The 
infrahepatic IVC clamp was then immediately re-applied and the suprahepatic IVC 
clamp released. This manouevre ensured that no residual UW solution, stagnant 
hepatic venous blood or air reached the systemic circulation. The infrahepatic IVC 
anastomosis was then completed using 9/0 nylon-140 m needle. These clamps were 
then released and inferior vena caval flow re-established. The portal vein, supra-
and infrahepatic vena cavae were all sutured by direct end-to-end anastomosis. 
Microvascular technique was employed using 8/0 nylon-140 m needle for the 
suprahepatic IVC and 9/0 nylon-140 m needle for the infrahepatic IVC and portal 
vein. The hepatic artery anastomosis was performed using the sleeve technique ( 66) 
and 10/0 nylon-70 m needle. Bile duct continuity was re-established over the 
polyethylene stent and secured with a 7 /0 silk tie. In all cases the liver was observed 
closely for the return of its normal colour and for evidence of bile production. The 
gut was observed for evidence of the return of normal portal venous circulation. 
12.2 Results. 
12.2.1 Survival. 
In the autograft group, 32 out of 80 animals survived to sacrifice ( 40% ). In the 
allografts, 30 out of 68 animals survived to sacrifice ( 44% ). At autopsy, 
haemoperitoneum was noted in approximately 40% of animals, suggesting technical 
failure (anastomotic bleeding) as the probable cause of death. No obvious cause for 
mortality was noted at autopsy in the remaining animals. These animals were 
usually those in which ischaemic times were delayed beyond 25 mins for technical 
reasons. 
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12.2.2 Aspartate aminotransferase (AST). 
In autografts an increase in AST over control values was noted at 4 and 24 hours 
(p < 0.05), with a tendency to be greater at other time intervals. In the allografts, 
significant increases in AST over partially hepatectomized controls occurred at 4 
hrs, 24 hrs and 48 hrs (p<0.01) (Table 12.1). There was a significant increase in 
AST in allografts as compared with levels in autografts at 24 hrs (p < 0.05) and at 48 
hrs (p < 0.01 ). 
Table 12.1 Aspartate aminotransferase (AST) after liver autograft and allograft in 
fasted rats. Results are expressed as means +- SE. * p <0.05 and** p <0.01 by 
ANOVA, with respect to partially hepatectomized controls (ph). 
TIME PH AUTOGRAFT ALLOGRAFT 
* ** 4 hrs 328+-40 998+-228 1300+-339 
* ** 24 hrs 390+-31 910+-164 1617+-470 
48 hrs 237+-16 496+-102 ** 985+-259 
72 hrs 192+-32 328+-121 256+-30 
96 hrs 111 +-9 106+-34 173 +-20 
12.2.3 Thymidine kinase (TK). 
In the autografts and allografts, activity was depressed up to 3.5 fold at 24 hours with 
respect to partially hepatectornized controls (p < 0.01 ). Peak thymidine kinase 
activity was observed at 48 hrs in both auto- and allografts (Figure 12.1-2). 
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12.3.4 Mitotic index. 
In both autografts and allografts, mitotic activity was significantly diminished at 24 
hrs ( 1 + -0) (p < 0.01 ). Maximal mitotic activity was demonstrated at 48 hours in both 
groups, ( autografts 13 + -7) and ( allografts 20 +-6) corresponding with the elevation 
in thyrnidine kinase at this time. No significant differences in mitotic index occurred 
at 72 hrs. The mitotic index for allografts was significantly less than controls at 96 
hrs (p < 0.05) (Figure 12.1-2). 
12.3.5 Liver mass index (LMJ). 
There were no differences between groups at 4 hours, reflecting the uniformity of 
partial hepatectomy. The LMI for both autografts and allografts was reduced at 24 
hrs (p < 0.05) and 48 hrs (p < 0.01) with respect to controls. The greatest increment in 
LMI was shown in the second 48 hour period in both groups. Restitution of liver 
mass to that of sham-operated animals occurred in both autografts and allografts by 
96 hours (Figure 12.1-2). 
12.3. 6 Tissue water. 
The mean liver tissue water was greater in the autografts (73.3%) than in controls 
(70%) at 24 hours (p < 0.01 ). In the allografts, tissue water was significantly greater 
than ph controls at 24 and 48 hrs (p<0.01) (Table 12.2). 
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Table 12. 2 Liver tissue water after liver autograft and allograft in fasted rats. Results 
are expressed as means + - SE. * p < 0. 05 and * * p < 0.01 by ANO VA, with respect to 
parlially hepatectomized controls. 
TIME AUTOGRA.Ff ALLOGRA.Ff 
4 hrs 71.6%+-0.5% 75.0%+-1.2% 
* ** 24 hrs 73.3%+-0.9% 78.8%+-2.2% 
48 hrs 74.9%+-0.9% ** 75%+-0.6% ** 
72 hrs 73.1 % + -0.4% 73.3%+-6.9% 
96 hrs 71.7%+-l.0% 73.4%+-5.5% 
12. 2. 7 Omithine decarboxyase ( ODC ). 
In both the transplant groups, the pattern of ODC activity was no different to that of 
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Figure 12.1 Influence of reduced orthotopic liver autotransplantation on hepatic 
regeneration in fasted rats. Partial hepatectomy was performed as a control ( clear bars) and 
compared to the reduced auto graft ( solid bars). Parameters of liver regeneration and 
sampling times were as previously indicated. Results were expressed as means+- SE. * 
p<0.05 and** p<0.01 by ANOVA. 
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Figure 12.2 Influence of reduced orthotopic liver allotransplantation on hepatic 
regeneration infasted rats. Partial hepatectomy was pe,formed as a control (solid bars) and 
compared to the reduced allograft ( clear bars). Parameters of liver regeneration and 
sampling times were as previously indicated. Results were expressed as means +- SE. * 
p<0.05 and** p<0.01 by ANOVA. 
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12.4 Discussion. 
The model for partial orthotopic liver transplantation. 
Orthotopic rat liver transplantation was first carried out by Lee et al (161,162) and 
later modified by Zimmerman (308). This model represented a significant advance 
in liver transplantation research, since it was a reliable model of solid organ 
transplantation that utilized inexpensive laboratory animals. In the first report, a 
portojugular extracorporeal shunt was utilized (161). However, this proved 
cumbersome and was the source of a number of technical difficulties and was 
therefore later abandoned (162). The first report of the technique utilized hepatic 
arterial anastomosis (161). However, it was subsequently reported by Lee that "the 
rat liver deprived of hepatic arterial flow not only tolerates transplantation well, but 
also functions normally in the host for an indefinite period" (162). Anastomosis of 
the hepatic artery was therefore abandoned in subsequent modifications of the 
technique (162,308). 
Difficulty in completing the suture anastomoses of the suprahepatic vena cava and 
portal vein within the limited safe anhepatic period, and problems in the control of 
the shunts created the necessity for a more expedient technique of rat liver 
transplantation. In response to this need, Kamada and Calne developed cuff 
techniques to facilitate the procedure (143). This enabled anhepatic times to be 
reduced from an average of 25 rnins for suture anastomosis ( 161 ), to approximately 
14 rnins (143). This shortened anhepatic time resulted in improved results and the 
redundancy of extracorporeal shunting (143). In the opinion of Kamada and Calne, 
such shunts are unnecessary if the anhepatic phase does not exceed 26 rnins (143). 
This technique was however criticized since it did not provide for reanastomosis of 
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the hepatic artery, at a time when the importance of hepatic arterialization was 
being increasingly recognized (50,97, 120,277,286). It should however be noted that 
the rat liver has a remarkable ability to survive dearterialized liver transplantation 
(143). Increased isograft survival has since been demonstrated in arterialized 
orthotopic rat liver allografts (74 ). Furthermore, improvement in graft morphology, 
elimination of unspecific cell-mediated in vitro reactivity and specific transplantation 
tolerance in fully allogeneic combinations has been demonstrated (74). The hepatic 
artery has been shown to be important in the prevention of biliary ischaemia and the 
subsequent development of biliary obstruction (97,120). Induction of MHC class II 
antigens does not occur in arterialized liver isografts, unlike nonarterialized 
isografts (97). In the light of these recent observations, there can be little dispute 
over the advantage of the arterialized rat liver transplantation model. 
Rat liver transplantation, as modified by Kamada et al has become an accepted 
model for the study of transplantation immunology and liver preservation (143,288). 
However, the use of the cuff technique precludes the autograft procedure, and the 
numerous advantages associated with it. 
This laboratory has previously reported on an alternate technique for intact 
arterialized liver transplantation in the rat (72,113). In this model direct suture 
anastomosis is employed for the venae cavae and the portal vein. The artery was 
anastomosed by using the sleeve technique (66). An intraluminal polyethylene stent 
for the bile duct is utilized as described by Kamada (143). In response to the need 
for a model of reduced-size liver transplantation in small, inexpensive laboratory 
animals, we have developed a model of reduced-size liver transplantation in the rat. 
This was tested in both the autograft and allograft applications, and found to be a 
reliable model of arterialized liver transplantation. Anhepatic times averaged 22 
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mins ( +-1 min) in the autograft group and 21 mins ( +-1 min) in the allografts. A 
recognized limitation in the technique is the need for a skilled microsurgeon 
capable of performing the superior vena caval and portal venous anastomoses in less 
than 25 mins. We have encountered significantly increased mortality when 
ischaemic times are extended beyond this. The advantages of the cuff techniques are 
recognized in this regard. However, the necessity for an autograft model precluded 
their use in this experiment. Furthermore, it is felt that rearterialization is vital in 
any study of liver regeneration. We believe that the sleeve technique has significant 
advantages in the hepatic arterial anastomosis (113). Unlike the performance of 
rapid portal venous anastomoses, it is an easily aquired and reproducible skill. 
Discussion of results. 
The results of this part of the study indicate a similar pattern of hepatocyte 
proliferation in both autograft and allograft groups to that observed in animals 
subjected to hepatic ischaemia only. This suggests that the single most important 
factor governing alterations in hepatocyte proliferative kinetics is warm hepatic 
ischaemia. The autografts differed little in the pattern of their response to the 
allografts. This would indicate that cold ischaemia, such as incurred during storage 
of the liver, has no additional effect on the subsequent regenerative response. 
Hepatic reperfusion injury has been observed in rat liver allotransplantation 
following 60 mins of cold preservation, manifesting primarily as an injury to the 
microvasculature (293). The reintroduction of blood-borne oxygen with generation 
of free oxygen radicals and resultant endothelial damage has been proposed as a 
possible mechanism of this injury (40,293). Significantly, no hepatocellular injury 
could be demonstrated following 30 mins warm ischaemia (293), suggesting that 
absorbed toxins from the gut are unlikely to be responsible. The results of our study 
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confirm those of Thurman et al (293), with significantly greater AST levels in 
allografts (warm ischaernic time 21 mins, cold ischaernic time 4 hrs) than in 
autografts (warm ischaernic time 22 mins). Damage after cold storage in this study 
may be due primarily to the effect of cold hypoxia on the endothelium. This has 
been proposed as a possible mechanism of injury in liver preservation ( 40). The 
possibility exists that damage to the rnicrovasculature caused by reperfusion injury 
may contribute to the subsequent immunologic and biliary complications seen in 
clinical transplantation. 
The loss of 17% of viable hepatocytes has been demonstrated following 60 mins of 
cold ischaemia (293). This deficit, added to the 68% partial hepatectomy performed 
in our study would result in an effective 75% hepatectomy, and a 25% partial graft. 
Interpretation of AST values should be seen in this context. In this study, AST 
values were greater in those animals in which storage of the liver had occurred, yet 
the proliferative response did not differ from those which were not stored 
(autografts). This would counter the contention that storage results in additional 
hepatocyte necrosis, greater loss of functional hepatocyte mass and a greater 
regenerative stimulus. At no time did recipients of stored livers demonstrate greater 
DNA synthesis or mitotic activity than either autografts or partially hepatectomised 
controls. 
In the experiments on hepatic ischaemia and in situ flushing, it was demonstrated 
that the initiation of the regenerative response was retarded. In allografts, where 
ischaernia, flushing and storage all occurred, the peak of DNA synthesis and mitotic 
activity was recorded at 48 hrs. Therefore, whilst ischaemia and flushing both result 
in a delay in the initiation of regeneration, their effect is not additive in 
combination. 
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Of note is the increased tissue water observed in the allografts, as compared to 
either the autografts or partially hepatectomized controls. This would be consistent 
with the swelling of hepatocytes known to occur with preservation (270). Cytokine-
mediated activation of the sinusoidal endothelium may account for the 
accumulation of intracellular and interstitial fluid (227). 
Increased plasma catecholamine concentrations have been demonstrated after 
intact rat (50) and pig (114) liver allografts. The role for the sympathetic nervous 
system, noradrenaline and the alpha-1 adrenergic receptor in the control of liver 
regeneration (62) has been previously described on page 119. Increased levels of 
circulating catecholamines following liver transplantation may therefore have a 
positive effect on the proliferative response following partial liver transplantation. 
A previous study of auxiliary and nonauxiliary liver allotransplantation performed in 
semiallogeneic rat combinations ( 109) has relevance in the discussion of the current 
study. Firstly, evidence of hypertrophy in the heterotopic 30% liver transplant was 
demonstrated in animals where the native liver was totally hepatectomized ( 109), 
although definitive markers of hepatocyte proliferation were not measured. Our 
findings, of 30% partial allografts in the orthotopic position confirm these findings. 
Secondly, compared to partially hepatectomized recipients, a state of donor-specific 
transplantation tolerance was observed in partial heterotopic allografts where total 
hepatectomy of the native liver was performed ( 109). This suggests that total 
recipient hepatectomy results in a state of immunologic privilege in the recipient, 
possibly due to the removal of the entire population of native Kupffer cells. This 
would tend to diminish the rate of rejection in this study, in which a fully allogeneic 
combination was used ( outbred LE X LE). 
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In summary, the results of this group suggest that although a delay in the initiation 
of the regenerative process was present, the hepatocyte proliferative response in 
autografts and allogeneic allografts appears intact, with restoration of normal liver 
mass by 96 hrs in both transplanted groups. This is further discussed in the following 
chapter. 
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13. CONCLUSIONS. 
The conclusions of this study, in brief, are as follows: 
1. Hepatic ischaemia of 40 minutes duration delays the onset of liver 
regeneration following partial hepatectomy. 
2. Portal venous stasis appears to enhance the proliferative response. 
3. Ischaemic hepatocyte damage does not result in a greater regenerative 
stimulus by amplifying the loss of functional hepatocyte mass. 
4. Portal venous occlusion results in significant mortality. This is alleviated by 
portal decompression by temporary portocaval shunt. 
5. Hepatic denervation by surgical means has no apparent effect on the early 
regenerative response. 
6. In situ liver flushing has a similar effect on the initiation of DNA synthesis to 
that observed in ischaemia. That is, the process is delayed by 24 hrs but is 
nevertheless complete by 96 hrs. There is no advantage of any one flushing 
solution over another in this regard. 
7. The regenerative process is complete by 96 hours in male Long-Evans rats, as 
measured by the restitution of the liver-body mass ratio. 
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8. Acceptable models of liver autograft and allograft have been demonstrated; 
these are successful provided that the necessary microsurgical skill is 
available. 
9. The technical procedure of liver transplantation has no direct implications in 
its own right on liver regeneration. 
10. The effects of ischaemia and liver flushing on liver regeneration are not 
additive when in combination, that is in the stored liver allograft. 
11. Despite an early delay in the initiation of the process, the regenerative 
response of the partial liver graft is largely unaffected by the multiple insults 
to which it is exposed during experimental transplantation. 
We have thus examined the effect of some of the diverse insults to which the liver is 
exposed at the time of transplantation, on the livers' regenerative capacity. 
Additional factors that may impact on the liver graft are not all potentially 
unfavourable. The immunosuppressive drugs cyclosporin (150) and FK 506 (89) 
have been shown to enhance DNA synthesis following partial hepatectomy, 
provided they are given prior to the operation. Allograft rejection has been shown to 
similarly enhance regeneration of intact liver grafts in rats (290). 
We believe then that the major factors that may alter the hepatocyte proliferation 
kinetics of the partial liver graft have now been examined in the rat. From this and 
other studies (9,248) it would appear that the ability of the partial graft to restore 
the normal liver to body ratio by regenerative growth is unimpeded in the long term. 
A concern however, is the delay in the initiation of the process. Liver regeneration 
in rats is normally complete by 7 days (32), whilst in man this process may take 3 
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months, increasing at a rate of approximately 70 ml per day (295). A delay of 24 
hours in the rat may therefore translate into a 2 week delay in man. This would 
imply that regenerative activity in the nascent partial liver graft may only commence 
on postoperative day 14. This might have significant implications if a rejection 
episode were also to occur. The immunosuppressive agents cyclosporin ( 150) and 
FK 506 (89) are reported to enhance regeneration if given prior to partial 
hepatectomy. Cyclosporin and FK 506 is reported to ameliorate the injury caused by 
ischaernia and reperfusion (147,149,151,254,255). A study is presently under way to 
determine the effect of the administration of these substances to rats following 
partially hepatectomy and hepatic ischaernia. 
The implications of this are that sufficient liver parenchyma will need to be 
transplanted to sustain bodily requirements during this period. Rejection and graft 
infection are compounding threats at this time. 
Hepatic regeneration is controlled by an equilibrium between humoral and hepatic 
growth factors and their specific hepatocellular receptors (166). Metabolic signals 
resulting from a smaller liver mass may result in the Go to G1 transition in 
transplanted liver graft. Subsequently autocrine effectors such as TGF alpha would 
induce transition to the S phase in the stimulated cell, whilst co-rnitogenic factors 
act on cells in the Go phase to result in either positive or negative effects on the 
cell. These factors include noradrenalin, vasopressin and angiotensin (194). It is 
likely that ischaernia acts to modify the effect of these so-called co-rnitogenic 
factors. At a cellular level, the mechanisms whereby ischaernia may do this may 
include obliteration of the TGF alpha/EGF or alpha-1 adrenergic receptor by 
cellular damage at the time of reperfusion, or by impairing the cellular production 
of rnitogens such as TGF alpha by a global depression of cellular metabolism. The 
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time course of the witnessed depression of parameters of cellular proliferation 
would suggest that permanent destruction of the receptor would be unlikely 
however, as the response has normalized by 48 hours. Other possibilities include the 
nonspecific depression of co-mitogenic substance release. 
Unanswered questions and further studies. 
In view of the apparent enhancement of the proliferative response following portal 
venous occlusion, and in the knowledge that endotoxaemia is associated with portal 
stasis (215), an important question is the effect of portal venous stasis on the 
expression of mitogenic cytokines. Portal and systemic endotoxaemia may form part 
of the physiologic process of liver regeneration. 
Computerized axial tomography (295) and magnetic resonance imaging may provide 
accurate assessments of the volume increase of liver transplants, but they provide no 
direct information about the proliferative status of the transplanted liver. The 
development of a noninvasive parameter of liver regeneration is therefore 
important. Alfa foetoprotein and epidermal growth factor have been suggested as 
such noninvasive parameters by Koch and Leffert (154). Further possibilties may 
relate to oncogene or heat shock protein expression in the transplantation context. 
Progress in the elucidation of the control mechanism of liver regeneration at a 
cellular level may however be necessary prior to the use of such a parameter in the 
clinical context. The ever present trap is the measurement of serum parameters of 
which the true significance is controversial or worse, unknown. 
Cyclosporin (150) and FK 506 (89) are known to enhance the proliferative response 
following partial hepatectomy. Obliteration of the observed delay in initiation of 
liver regeneration following transplantation is therefore a possible effect of these 
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drugs. This in turn would beg the question of whether the immunosuppression 
provided by these drugs alters the regenerative response of reduced liver 
transplantation in different allogeneic combinations. A enhanced proliferative 
response has previously been observed in intact liver grafts in fully allogeneic 
combinations (290). 
The measurement of hepatocyte-specific synthetic function following 
transplantation is important, as is the question of how this is temporally related to 
liver regeneration. A delay in regenerative activity following transplantation may 
occur at a time when the liver is concerned with the synthesis of essential proteins. 
Given the near normal ability of the liver to regenerate following transplantation, 
what is the minimum hepatocyte mass that can be safely transplanted into a 
recipient? It would appear that the limitation in this regard may be the maintenance 
of normal liver function in the period between transplantation and restitution of 
liver size to normal, rather than concern as to the liver segment's regenerative 
capacity. Further studies of this nature are therefore needed, since the proliferative 
status and kinetics of cellular proliferation of human transplanted liver are not 
known. 
The answers to these questions may yet provide insight into the outcome of reduced 
liver transplantation surgery and the nature of the ideal liver mass. 
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